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One Sentence Summary: 
We have discovered a novel strain of bacteria upon a frequent viral background underlying 
postinfectious hydrocephalus in Uganda. 
Abstract 
Postinfectious hydrocephalus (PIH), often following neonatal sepsis, is the most 
common cause of pediatric hydrocephalus world-wide, yet the microbial pathogens remain 
uncharacterized. Characterization of the microbial agents causing PIH would lead to an 
emphasis shift from surgical palliation of cerebrospinal fluid (CSF) accumulation to prevention. 
We examined blood and CSF from 100 consecutive cases of PIH and control cases of non-
postinfectious hydrocephalus (NPIH) in infants in Uganda. Genomic testing was undertaken for 
bacterial, fungal, and parasitic DNA, DNA and RNA sequencing for viral identification, and 
extensive bacterial culture recovery. We uncovered a major contribution to PIH from 
Paenibacillus, upon a background of frequent cytomegalovirus (CMV) infection. CMV was only 
found in CSF in PIH cases. A facultatively anaerobic isolate was recovered. Assembly of the 
genome revealed a strain of P. thiaminolyticus. In mice, this isolate designated strain Mbale, 
was lethal in contrast with the benign reference strain. These findings point to the value of an 
unbiased pan-microbial approach to characterize PIH in settings where the organisms remain 
unknown, and enables a pathway towards more optimal treatment and prevention of the 
proximate neonatal infections. 
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Introduction 
 
Hydrocephalus is the most common indication for neurosurgery in children. Of the 
estimated 400,000 new cases each year, about half are estimated to be postinfectious, with the 
largest number of cases in low- and middle-income countries, especially sub-Saharan Africa (1). 
Neonatal sepsis (2) often precedes postinfectious hydrocephalus (PIH) (3), although the 
manifestations of hydrocephalus typically emerge in the months following the neonatal period as 
sufficient cerebrospinal fluid (CSF) accumulates so that cranial expansion garners medical 
attention. Thus, although these infants will typically die in early childhood without advanced 
surgical management, they are omitted from neonatal mortality surveillance (4).  
The spectrum of microbial agents that underlie PIH remains poorly characterized. It is 
known that seasonal Neisseria epidemics can produce such cases within the African meningitis 
belt (5), and there have been reports of a tendency towards gram negative coliform bacteria in 
infants in other Southern (6) and Eastern (7) African locations where Neisseria is uncommon. 
Nevertheless, there has never been a well-controlled examination of the agents underlying PIH, 
and no knowledge of the roles that viruses, parasites, or fungi might play in addition to bacteria. 
If the microbial agents causing PIH were better characterized, emphasis could shift from high 
technology palliation of CSF accumulation (8) to prevention. 
In this study, we examined blood and CSF from 100 consecutive cases of PIH and 
control non-postinfectious hydrocephalus (NPIH) in infants under 3 months of age at the CURE 
Children’s Hospital of Uganda (CCHU) in Mbale, Uganda. Since 2001, this pediatric 
neurosurgical hospital has treated thousands of PIH and NPIH cases, with nearly uniformly 
negative recovery of putative pathogens through standard bacterial culture. In this study, we 
gathered high quality blood and CSF samples for molecular analysis, and comprehensive 
testing was undertaken for bacterial, fungal, and parasitic DNA, genomic and RNA transcript 
sequencing for viruses, in addition to extensive bacterial culture recovery efforts for taxonomic 
identification, genome assembly and virulence characterization. 
 
 
Results 
 
Demographics & clinical characteristics 
 
Between March and November 2016, 115 consecutive patients were screened, and 15 
were excluded for the following reasons: 8 did not give consent, 6 lived outside of Uganda 
(South Sudan and Kenya), and 1 weighed less than 2.5 kg. A total of 100 patients 3 months of 
age or younger with hydrocephalus were enrolled; 64 with PIH and 36 with NPIH. PIH patients 
were on average several weeks older than NPIH patients (whose disorders were generally 
recognized at birth), and had higher peripheral and CSF white blood cell counts, lower blood 
hemoglobin and hematocrit levels, but were evenly distributed by sex and HIV exposure status 
(Table 1).  
Prior to admission for hydrocephalus, 15 infants received antibiotics, but we only have 
records detailing antibiotic type for 2 of these 15 patients (gentamicin with ampicillin in one case 
and gentamicin with ceftriaxone in the other case). Three patients received antibiotics for 
treatment of active infection at CCHU after admission (ceftriaxone with gentamicin in one case, 
and ceftriaxone alone in the others). Such antibiotic treatment is adjunctive to abscess 
management (drainage and irrigation of larger accessible abscesses), prior to more definitive 
surgical treatment of hydrocephalus with endoscopic third ventriculostomy or insertion of a 
ventriculoperitoneal shunt (8). 
Preoperative CT scans were scored, demonstrating that PIH patients were more likely to 
have evidence of CSF fluid loculations, debris within fluid spaces, ectopic calcification, and brain 
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abscesses (Table 1 and Fig. S1). The homes of PIH patients were concentrated within central 
and eastern Uganda, in a swampy plateau north of Lake Victoria, and south and north of the 
banks of Lake Kyoga, while NPIH patients were more uniformly distributed geographically (Fig. 
1 and Fig. S2, p=0.03 by linear discrimination).  
 
Bacterial pathogen detection 
 
For bacterial pathogen discovery, both Sanger sequencing of 16S rDNA V1-V4 region 
and next generation sequencing of V1-V2 and V4 regions were performed on fresh frozen and 
preserved specimens in two different laboratories, which enabled us to account for known 
variation in microbial community amplicon sequencing (9), and demonstrate reproducibility of 
our findings. 
Using DNA from fresh frozen CSF, conventional PCR targeting the V1-V4 16S rDNA 
gene region (Table S1) revealed 16S amplification in 27/64 PIH and only 3/36 NPIH patients. 
V1-V4 Sanger sequencing of subcloned amplicons identified Paenibacillus as a predominant 
organism within the PIH cohort (23/64), but not within the NPIH cohort (0/36). The full results 
from this method are summarized in Table S2. For quantification of Paenibacillus in CSF, 
Paenibacillus genus-specific qPCR was performed confirming and quantifying 22 of the 23 
samples that were positive for Paenibacillus by Sanger sequencing and identifying 4 additional 
positive cases (Fig. 2A and 2B). Next generation sequencing on 16S rDNA V4 region was 
performed on all samples from which amplification libraries could be obtained with composite 
MiSeq primers (26/64 PIH and 3/36 NPIH) (Fig. 2C). Only a few nucleotides distinguished P. 
thiaminolyticus and P. popilliae within the V1-V4 region, hindering species-level discrimination 
between these taxa. From the V1-V4 sequencing data a phylogenetic tree was constructed, 
revealing that the majority of the Paenibacillus V1-V4 sequences were most closely related to P. 
thiaminolyticus and P. popilliae, and sequences from one subject that most closely matched P. 
alvei (Fig. S3). 
Using DNA from samples in genomic preservative, next generation sequencing was 
performed on V1-V2. Overall, representative sequences from the 1,767 operational taxonomic 
units (OTUs) matched 159 genera. The majority of OTUs were sparsely represented except for 
a number of known skin flora, e.g., Propionibacterium spp. (Fig. 2D). Over half of the reads in 
20% of the patients were attributed to the genus Paenibacillus. Paenibacillus spp. were present, 
defined as a minimum of 50 reads, in 38 PIH patients and 2 NPIH controls (Fig. 2D).  
To associate taxa with infection we aggregated annotated OTUs at the genus level and 
performed differential abundance analysis. In performing linear regression analysis 
(Supplemental Methods: Differential Abundance Analysis), Paenibacillus was the only genus 
associated with PIH following multiple testing correction (Table S3). Paenibacillus spp. 16S 
rDNA abundance was used as a biomarker for classifying PIH patients and was consistent 
between V1-V2 and V4 (Fig. 2E). A receiver operating characteristic analysis yielded an area 
under the curve of 70.9% (95% DeLong CI = 60.6%-81.1%) for V1-V2 (Fig. 2F, Fig. S4A), with 
an optimal threshold just below 50 reads. 
The spatial distribution of PIH and PIH Paenibacillus positive cases was significantly 
different from control NPIH cases (Fig. 1, Fig. S2). 
Other putative pathogens detected by 16S in individual patients at high abundance 
included sequences consistent with Bacillus subtilis and Streptococcus agalactiae (Fig. 2C and 
2D, Table S2). Diversity decreased as Paenibacillus abundance increased (Fig. S4B). The 
majority of CSF samples had similar microbial background leading to no clear visual separation 
of PIH and NPIH when diversity (beta) was visualized with principal coordinates analysis 
(PCoA) plots to reduce the dimension (Fig. S4C). Limiting to the set of OTUs annotated as 
Paenibacillus spp. revealed two or three clusters of patients with similar Paenibacillus 
abundance distributions in positive patients (Fig. S5). Further analysis on the microbial 
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communities, including comparison of 16S regions and the characterization of isolates’ 
taxonomy, is described in Supplementary Methods (microbial characterization: taxonomic 
assignment and overview and differential abundance analysis). 
 
Viral pathogen detection 
 
Utilizing the targeted viral detection capture technique VirCapSeq-VERT (10), we 
observed evidence of 11 viral strains distributed across 36% of samples — 32.8% (PIH) and 
41.6% (NPIH) (Table S4). Only Human Herpesvirus 5 (cytomegalovirus, CMV) was present at 
substantial abundance, confirmed by requiring positive findings on at least two replicates in two 
different qPCR methods (Supplementary Materials, Table S4) applied to all 100 preserved CSF 
and blood samples. CMV was confirmed in 27/100 patients (27/99 blood: 18/64 PIH, 9/35 
NPIH), but CMV was found only in the CSF in blood CMV positive PIH cases (8/100 CSF: 8/64 
PIH, 0/36 NPIH) (Fig. 3A). RNA sequence data confirmed 4 cases of CMV by sequence 
matches to multiple mRNA transcripts (Fig. 3A).  
The spatial distribution of CMV positive cases was not significantly different from control 
NPIH cases (Fig. 1, Fig. S2). 
 
Paenibacillus correlates with clinical signs 
 
Several clinical measurements were positively associated with Paenibacillus presence 
including CSF cell count and CT scan scores.  
In 12 months of follow-up, there were 5 deaths: 3 PIH and 2 NPIH patients. Each of the 
PIH deaths were in patients with Paenibacillus. 
Paenibacillus spp. abundance was inversely correlated with patient age, consistent with 
residua from neonatal infection (Fig. 4A, Fig. S6, Kruskal-Wallis, P<0.05). Only PIH patients had 
high CSF cell counts (>5/μL); all were positive for Paenibacillus in the top abundance quartiles 
(Fig. 4B, Fig S6). Infants with hydrocephalus may have considerable extra weight in their heads 
from CSF relative to their body mass, and after calculating and subtracting excess fluid volume-
for-age (11, 12), we found no difference between this corrected weight-for-age with 
hydrocephalus or Paenibacillus status (Fig. 4C).  Seizures were more commonly reported in 
patients prior to admission (25 vs 13) and during hospital admission (9 vs 1) in patients who 
were Paenibacillus positive. The mean (SD) number of estimated days from initial febrile 
episode to when the head was noted to be growing was 21.4 (16.4) versus 29.3 (25.4) for 
Paenibacillus positive versus negative cases. Bloody CSF was noted in 15 CSF samples, but 
did not account for Paenibacillus positivity (1/7 positive in PIH), or the presence of CMV in CSF 
(0/15 positive in PIH or NPIH). 
 Brain image CT scan scoring representative of brain abscesses, calcifications, 
loculations, and debris was calculated using preoperative imaging. PIH patients without 
measurable Paenibacillus had higher scores than NPIH patients, and PIH patients positive for 
Paenibacillus had significantly higher scores compared to PIH patients without Paenibacillus 
detected (Fig. 3B, 3C, Table S5, Figures S1, S6 and S7). All of the CSF positive CMV patients 
were PIH patients (Table S6), and each had at least one of the four signs comprising the CT 
score: 6/7 fluid loculations, debris within fluid spaces, or ectopic calcification, and 5/7 abscess 
(Table S7). We fit an ordinal logistic regression model that included PIH vs NPIH status and 
Paenibacillus presence. Patients with PIH had increased proportional odds for high CT score, 
OR (95% CI) = 11.66 (4.29, 33.94) as well as Paenibacillus presence, OR (95% CI) = 7.6 (3.06, 
19.88). Testing for CMV presence did not show increased proportional odds of high CT scan 
scores (Fig. 3D), OR (95% CI) = 3.30 (0.52, 29.66), when controlling for hydrocephalus etiology 
and Paenibacillus presence. 
Growth and characterization of Paenibacillus strain 
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From 600 initial cultures from fresh frozen CSF (Table S8), 12 isolates were recovered 
from 7 patients (Table S9). Two isolates of Paenibacillus were recovered from cultures using 
small volumes (50 µl) of fresh frozen patient samples, and 1 from the blind culture of a lytic 
anaerobic bottle (BD BACTEC). These were identified as Paenibacillus spp. using MALDI-TOF 
(Table S9). Of the three inoculum recoveries, two grew from subculture or blind culture onto 
solid media, identifying them as facultative anaerobes, while the third was never successfully 
subcultured. Marker gene analysis of the three Paenibacillus isolates were identified as P. 
thiaminolyticus, P. amyloliticus, and Paenibacillus sp. (Fig. 5, Supplementary Methods: 
phylogenetic tree placement). The 16S rRNA genes from the whole genome sequences of all 3 
isolates were compared to the 16S amplicon V1-V2 OTU cluster representative sequences. The 
P. thiaminolyticus isolate was most similar to that of OTU 99373, the most dominant OTU 
annotated as Paenibacillus within Paenibacillus-positive patients (Fig. S5). This identified the P. 
thiaminolyticus strain (hereafter, strain Mbale) as our isolate of interest for the subsequent tests 
for virulence in mice. Further, we compared this strain by 16S rRNA gene similarity, average 
nucleotide identity (ANI) (http://enve-omics.ce.gatech.edu/ani/) (13), and biochemical testing 
against the P. thiaminolyticus type strain NRRL B-4156T (=JCM 8360T,GenBank accession 
CP041405). The 16S rRNA genes of this isolate had 99.2%-99.4% identity, and the whole-
genome average nucleotide identity (gANI) value was 97.06%, well above the 94-96% species 
threshold (14). Biochemical testing (https://apiweb.biomerieux.com, Table S10) had a 99.5-
99.9% identity confirming that this isolate belongs to P. thiaminolyticus (15, 16). Antibiotic 
sensitivity was tested and the Mbale strain was broadly sensitive to common antibiotics (Table 
S11). 
  
Thiamine testing 
 
 We tested for thiamine deficiency assaying for thiamine diphosphate (TDP) levels in 
whole blood. PIH cases (positive and negative for Paenibacillus) had lower TDP blood levels 
than NPIH cases (Fig. 3E, t-test, p<0.05). 
 
Pathogenicity of Paenibacillus strain Mbale 
 
 Comparative virulence was assessed between the reference strain NRRL B-4156 and 
the strain Mbale in age-matched C57BL/6J mouse littermates of both sexes inoculated 
intraperitoneally at postnatal days 21-28. The reference strain demonstrated no adverse effects 
on the mice, while the strain Mbale produced illness in all mice (16/16), with mortality or 
moribund states in 15/16 (93%) of animals inoculated at a comparable concentration of colony 
forming units (Fig. 6, Table S12). The Mbale strain produced acute tubular necrosis in the 
kidneys, bone marrow myeloid hyperplasia, and moderate lymphocyte apoptosis in the splenic 
periarteriolar sheaths, but there were no significant brain lesions (Fig. 6). 
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Discussion 
 
Postinfectious hydrocephalus may be the largest single cause of childhood 
hydrocephalus and the need for neurological surgery in children worldwide. These cases are 
concentrated in low- and middle-income countries (1), and the dominant predisposing event is 
often neonatal sepsis. Although such hydrocephalus is in principle preventable, the microbial 
spectrum that accounts for this disease, and the routes of infection, have never been well 
characterized.  
We have therefore taken a very broad view to this disease, proposing that an unbiased 
identification of pathogens may be necessary to identify potential causal factors in developing 
world settings, drawn from the neonatal septisome (17) — the assemblage of the pathogens 
underlying neonatal sepsis in such settings. 
Postinfectious hydrocephalus is part of a spectrum of conditions that through activation 
of the immune system in the brain lead to acquired hydrocephalus. The other major component 
of post-inflammatory hydrocephalus of infancy is intracerebral hemorrhage of prematurity. Both 
infection and hemorrhage within the brain lead to hydrocephalus through related inflammatory 
mechanisms (18). PIH is not a disease caused by a single organism, and the use of an 
unbiased pan-microbial analysis in other regions will likely reveal other organisms as important 
causes of PIH.One of the problems with utilizing genomic techniques for pathogen detection 
from nominally sterile body fluids, such as blood and CSF, is that such low-biomass samples 
are plagued by bacterial DNA contamination from reagents and other sources that can dominate 
the results (19), and substantial effort has addressed both statistical (20) and spike-in strategies 
(21) to reduce such effects. By employing case-controls in our study consisting of 
contemporaneously recruited NPIH patients referred to the same hospital, we were able to 
rigorously contrast our analysis of infected samples to that of clinically uninfected controls. By 
replicating our bacterial discovery efforts on differently preserved samples, in independent 
laboratories with separate regions of 16S, we reproduced convergent results — demonstrating a 
dominant Paenibacillus PIH pathogen in this cohort.  
Whether prior analysis of postinfectious hydrocephalus in this region was biased by 
reagent contamination is not known at this time (7), but we implemented several technical 
strategies to reduce the effect of background contamination (see Supplementary Material). 
Despite such contamination reduction efforts, the additional use of case-controls was critical to 
achieve convincing levels of differential abundance significance, along with validation through 
organism recovery in culture from cases. The organism culture recovery rate was low, 
potentially due to the use of fresh frozen samples and antibiotic administration prior to patient 
sampling. 
While various Paenibacillus spp. have been occasionally isolated from CSF (22-24), P. 
thiaminolyticus has not been known to be a virulent pathogen. It was first identified while 
screening for bacteria in the gut that might contribute to thiamine deficiency in beriberi in Asia 
(25). There is a single case report of indwelling catheter-associated bacteremia in an elderly 
patient on hemodialysis (26). This bacterium produces thiaminase I and II and is adapted to live 
in low-thiamine environments. Thiamine deficiency is associated with Wernicke’s 
encephalopathy (27), two forms of beriberi (28), and polioencephalomalacia-associated brain 
necrosis in ruminant animals (29). In the developing world, thiamine deficiency is common in 
children (30), and is exacerbated by the stress of infection (31). Our findings demonstrate that 
thiamine levels were lower in postinfectious children regardless of infectious etiology, but, 
consistent with reports in animals (32), we did not demonstrate lower thiamine levels specifically 
due to infection with P. thiaminolyticus.  
The underpinnings of the organism’s virulence remain uncharacterized at present. We 
found it difficult to culture this facultatively anaerobic organism from clinical samples. Once 
established in culture, the organism could be passaged onto aerobic media. We speculate that 
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with a predilection to form calcified loculations and abscesses within the brain, it may be 
growing anaerobically when sampled, and require initial anaerobic conditions before switching 
to aerobic metabolism. Alternatively, the lytic properties of the anaerobic broth used 
successfully in recovery might have released viable organisms from intracellular phagocytosis 
within white blood cells. In either case, this organism has acquired substantial virulence in 
comparison with the existing reference strain, as demonstrated by nearly complete lethality of 
high concentrations of this organism when inoculated into mice in contrast with the reference 
strain. Supporting this differential virulence are multiple phage insertions into its genome, and 
other protein coding and copy number variations, that await further characterization.  
The expression of differential virulence found in mice was constrained by the rapid 
lethality. The apparent toxin effect may have precluded replicating the establishment of the brain 
infections during sepsis which are the hallmark of PIH. Although our findings and animal model 
do not meet Koch’s postulates for disease causation (33), many infectious disease do not meet 
these criteria (34), and in particular PIH can be caused by different organisms. Nevertheless, P 
thiaminolyticus Mbale was the dominant organism present in these PIH cases, correlation with 
disease severity on brain imaging was substantial, and correlation with central and peripheral 
WBC counts was strong.  
Although this organism appears quite sensitive to common antibiotics, the presence of 
calcified abscesses will make the penetration of antibiotics to achieve adequate bactericidal 
concentrations challenging. Ideally, such concentrations are achieved at initial point-of-care 
treatment for neonatal sepsis prior to infection of the brain. It is possible that within the immune-
privileged brain (35), inadequate treatment during neonatal sepsis is a substantial factor in the 
persistent development of brain P. thiaminolyticus infection. How co-infection with CMV might 
affect disease severity in the setting of P. thiaminolyticus Mbale infection is unknown at this 
time. 
The typical clinical picture of these PIH cases is that of a ventriculitis without prior 
meningitis. Whether lumbar puncture in such infants, without meningeal infection, could be 
diagnostic during their neonatal sepsis evaluation is presently unknown.  
Notwithstanding that we find CSF purulence, high levels of matching DNA, and 
recovered organisms whose DNA matches that in infected cases closely, a full description of 
causality in this disease may be more complex. Our analysis was limited to detection of active 
infections. For the regions in which we were working, in utero exposure to infections such as 
malaria is common (36). But predisposing in utero infections which are no longer active after 
birth (whether parasitic, viral, or bacterial), would remain undetected in our genomic sampling. 
Our finding of a substantial viral background infection with CMV cannot distinguish congenital 
from postnatally acquired viral infection, but the true incidence of in utero infections must have 
been higher than what we could observe through testing several months after birth. In addition, 
our analysis does not address the heterogeneity in innate immunity (37) or nutritional status (38) 
known to be predisposing factors of infection.  
The demographics of the Paenibacillus infections suggests localization to a 
circumscribed region in Eastern Uganda. This is a region associated with the north and south 
banks of Lake Kyoga, and the wetlands along the northern edge of Lake Victoria. It is 
characterized by large swamps and is a rice-growing region. Whether these infections are 
influenced by rainfall (39), which has been previously observed in PIH without organism 
identification (40), or share similarities with other environmental agents in similar topographies 
of the developing world (41), remains unknown. 
Nevertheless, a pan-microbial approach has uncovered the presence of a difficult to 
grow pathogen not previously known to possess substantial virulence, which appears 
associated with calcified loculations and brain abscesses in infants, as well as with 
hydrocephalus following survival from neonatal sepsis. The presence of this organism upon a 
neurotropic viral background creates a scenario with frequent viral-bacterial coinfections where 
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6/8 CMV by CSF and 11/27 CMV by blood positive cases were co-infected with Paenibacillus 
spp. Prior studies in Ugandan adults have found that CMV viremia is frequently present in the 
setting of sepsis and is associated with increased risk of mortality (42-44). It has been 
hypothesized that immune modulation (45), rather than direct CMV effects, are responsible for 
the association of CMV with worse outcomes, especially for tuberculosis and cryptococcal 
meningitis. It is likely that, in many of these cases, latent CMV reactivates when overwhelming 
infection by another pathogen alters the immune system's ability to keep the virus sequestered 
(44, 45). However, due to the ages of our patients, all <90 days of age, a majority of the CMV 
viremias detected would be expected to be related to primary CMV infection (acquired either 
congenitally or during early postnatal life) and be more likely to cause, rather than be a cause 
of, alterations in immune function with related increases in bacterial pathogenesis and increased 
risk of severe bacterial infection (46).  
Limitations to this study are important to note. PIH is a syndrome, and although we have 
identified a novel agent that appears to play a major role in the cases from Eastern Uganda, it 
remains unclear what other bacterial pathogens may play an important role in other regions of 
Uganda, or other countries within sub-Saharan Africa and beyond. Whether Paenibacilus spp. 
predisposes to invasion of the nervous system by CMV, or vice versa, remains unknown at 
present. The non-diagnostic PIH cases are mysteries, in that the ectopic calcifications seen 
commonly in the Paenibacillus positive cases would not have disappeared in the slightly older 
cohort of non-diagnostic patients – it is possible that they may have harbored different 
organisms. The prime limitation to our pan-microbial molecular approach seems to have been 
the age of the patients – only survivors of neonatal sepsis can develop PIH, and our data is 
consistent with a need to identify the causative organisms as early as possible, ideally during 
treatment of neonatal sepsis accompanied by serial brain imaging. 
Addressing the estimated 160,000 annual cases of PIH generated largely throughout the 
developing world (1), and the larger pool of several million yearly neonatal sepsis cases (2), is a 
critical global public health need. If a pan-microbial approach is required, then the current 
technology available to achieve this is at present neither readily scalable nor economically 
sustainable. On the other hand, the expansion of high-technology surgical facilities and pediatric 
neurosurgical care is also not readily scalable (47). Long-term, more sustainable and less 
expensive technologies to achieve pan-microbial surveillance in such settings, including 
maternal and environmental sources of infection, will be required to enable more optimal 
treatment and ultimately prevention of these devastating neonatal infections. 
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Methods 
 
 Study design and oversight. The study was conducted at the CURE Children's Hospital 
of Uganda (CCHU), a freestanding pediatric neurosurgical hospital in eastern Uganda that 
serves as a countrywide referral center for patients with hydrocephalus. Infants were eligible for 
participation in the trial if they were 3 months of age or younger, met criteria for postinfectious or 
non-postinfectious hydrocephalus (PIH and NPIH respectively), and had a mother who was at 
least 18 years of age. The study was designed as a waste-fluid study at surgery with verbal 
consent. Ethics oversight was provided by the CCHU Institutional Review Board, the Mbarara 
University of Science and Technology Research Ethics Committee, and with oversight of the 
Ugandan National Council on Science and Technology. The study was approved by the Penn 
State University Institutional Review Board, and a Materials Transfer Agreement was in place 
between CCHU and Penn State University. A US Centers for Disease Control permit for the 
importation of infectious materials covered the transfer of specimens from CCHU to Penn State. 
An Institutional Biosafety Committee provided oversight of specimen handling at Penn State. A 
Materials Transfer Agreement between Penn State and Columbia University covered the 
transport of materials between these research sites.  
 Inclusion criteria for PIH: a) age 3 months or less, b) weight greater than 2.5 Kg, c) no 
history consistent with hydrocephalus at birth, and either i) a history of febrile illness and/or 
seizures preceding the onset of clinically apparent hydrocephalus, or ii) alternative findings such 
as imaging and endoscopic results indicative of prior ventriculitis including septations, 
loculations, or deposits of debris within the ventricular system (3), and d) mothers at least 18 
years old to give informed consent.  
Inclusion criteria for NPIH: a) age 3 months or less, b) weight greater than 2.5 Kg, c) 
findings of non-infectious origin of hydrocephalus on computed tomography (CT) scan or at 
endoscopy such as a lesion obstructing the Aqueduct of Sylvius such as tumor or cyst, 
aneurysm, or cavernous malformation, Dandy-Walker cyst, or other congenital malformation of 
the nervous system, or d) evidence of hemorrhage as cause of hydrocephalus such as i) bloody 
CSF and ii) absence of findings consistent with PIH or congenital origin of hydrocephalus, and 
e) mothers at least 18 years old to give informed consent. 
Exclusion criteria for hydrocephalus study: a) prior surgery on the nervous system 
(shunt, third ventriculostomy, or myelomeningocele closure), or b) evidence of communication of 
nervous system with skin such as meningocele, encephalocele, dermal sinus tract, or fistula. 
Statistical Methods. Continuous demographic variables were evaluated using the non-
parametric Wilcoxon rank-sum (two-group comparisons) and Kruskal-Wallis (>2 groups) tests 
following Shapiro-Wilk's test for normality, unless otherwise stated. Fisher’s exact test was 
performed for categorical variables. All tests were two sided unless stated otherwise. Ordinal 
logistic regression was applied to estimate the proportional odds of CT scan scores between 
indication, Paenibacillus presence or absence, and CMV status.  We performed differential 
abundance analysis of taxa abundances between PIH and NPIH groups and accounted for 
multiple testing leveraging false discovery rate analysis (48). 
Brain image evaluation. Preoperative CT scans were independently scored, blindly with 
respect to diagnosis, by two board certified neurosurgeons who have considerable experience 
with infant hydrocephalus (BCW, SJS). One point was assigned for each of four possible 
findings: fluid loculations, debris within fluid spaces, ectopic calcification within the brain 
parenchyma, and abscess formation. Discrepancies between scoring were then resolved to a 
consensus agreement. 
 Sample collection and storage. Blood was sampled with aseptic technique at the time of 
surgery, either at the time of catheter placement for an intravenous line or during venipuncture 
for routine laboratory testing. CSF was obtained at the time of initial surgery. Many of the PIH 
cases were treated for abscess formation once or twice, prior to a definitive surgical procedure 
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to address the hydrocephalus (endoscopic third ventriculostomy with choroid plexus 
cauterization, or ventriculoperitoneal shunt insertion). Initial surgery might not employ an 
endoscope if the primary goal was aspiration and irrigation of purulent material from loculated 
fluid collections or frank abscesses. These initial procedures might also include endoscopic 
lateral terminalis and septum pellucidum fenestrations. The endoscope was nearly universally 
used in all other cases, such as NPIH, as is our standard practice at this surgical site. Samples 
of blood and spinal fluid were divided into aliquots for fresh freezing or placement into DNA/RNA 
preservative (DNA/RNA Shield, Zymo Corporation), and specimens were frozen either at -80o C 
or placed in a liquid nitrogen Dewar or dry shipper. They were kept frozen through transport to 
the US for further analysis. 
 Ribosomal RNA (rRNA) 16S gene sequencing. For characterization of bacterial species 
we performed 16S rDNA amplicon sequencing. Separate CSF samples were sequenced at two 
different laboratories. Independent approaches were applied to limit background amplification of 
contaminants and decontaminate reagents (see Supplementary Materials). At one laboratory, 
16S amplicon sequencing of the V1-V4 region was performed on fresh frozen samples using 
Sanger sequencing. Further next generation amplicon metabarcode sequencing was performed 
on V4 for microbial background characterization, and Paenibacillus genus-specific qPCR for 
quantification was performed. At the other laboratory, a primer extension technique for 16S 
amplicon next generation sequencing of the V1-V2 region on DNA/RNA preserved samples was 
performed. Utilizing results from these two laboratories, 16S amplicon (regions V1-V2 and V4) 
reads sequenced from fresh frozen CSF and preservative samples were clustered at 97% 
similarity (49). For downstream analyses we accounted for sequencing variability using 
cumulative sum scaling normalized taxa abundances (50). A primer table is given in Table S1. 
Targeted pathogen gene testing. Targeted polymerase chain reaction (PCR) was 
performed in an attempt to detect the presence of Zika virus, chikungunya virus, human 
papilloma virus, parvovirus B19, toxoplasmosis, trypanosomiasis, malaria, and fungi (Table S1). 
Virus detection. A broad screen for viral presence was performed in two different ways: 
VirCapSeq oligomer concentration (10) and total RNA sequencing analysis. For the viruses that 
appeared abundant in either PIH or NPIH, PCR confirmation was performed.  
 Metabolites. Thiamine diphosphate was quantified in fresh frozen blood using high-
performance liquid chromatography with tandem mass spectrometry (LC/MS/MS) at Mayo Clinic 
Laboratories. 
 Microbiology. In an attempt to culture the putative pathogen, 100 fresh frozen CSF 
samples were subjected to 6 different media outlined in Table S8. If colonies grew on solid 
media, gram stain and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) 
were performed to characterize the organism. For isolates identified as Paenibacillus, antibiotic 
sensitivity, biochemical testing, and whole genome sequencing were performed. 
 Genome assembly. A hybrid method was utilized to reconstruct the genome of a P. 
thiaminolyticus isolate, combining short read sequencing, optical mapping (Bionano Genomics), 
and nanopore long contiguous sequencing (MinION, Oxford Nanopore Technologies). From the 
resulting whole genome sequences and optical mapping assembly a hybrid scaffold was 
generated (Bionano Hybrid Scaffold v1025201). For P. amylolyticus and Paenibacillus spp. 
isolates, and reference type strain P. thiaminolyticus NRRL B-4156 (Agricultural Research 
Service Culture Collection https://nrrl.ncaur.usda.gov/cgi-
bin/usda/prokaryote/report.html?nrrlcodes=B-4156), only short read and nanopore sequencing 
were utilized for assembly.  
 Animal model virulence testing. All animal experiments were performed with oversight by 
the Penn State Institutional Animal Care and Use Committee, and with Institutional Biosafety 
Committee approval at biosafety level 2 (BSL2). Virulence testing was performed on weanling 
P21-P28 C57BL/6J mice using up to 109 colony forming units suspended in 100 μL saline, or 
saline only, injected into the peritoneum. Bacteria for injection were thawed and subcultured 
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prior to each inoculation and quantified using standard colony forming unit methods 
(Supplementary Material). Animals were humanely euthanized with CO2 if they developed 
altered or depressed mentation, or lost more than 20% of their body weight. A full complement 
of tissues were collected from each mouse following the guidelines set forth by international 
veterinary toxicology interest groups (51-53). Tissues were preserved in 10% neutral buffered 
formalin, embedded in paraffin blocks, cut into 3 μm sections, and stained with hematoxylin and 
eosin for analysis. All organs were evaluated by a veterinary pathologist (HA). 
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Figure Legends 
 
Figure 1. Comparative location of cases within map of Uganda. The village centroid GPS 
locations are mapped to the 0.1 x 0.1 degree grid frequently used in satellite rainfall estimation 
(54), and where village name was uncertain, the centroid of the administrative parish or sub-
county was used. The groups shown are mapped by clinical status (NPIH and PIH), and by 
organism type (Paenibacillus, PAENI; cytomegalovirus, CMV). Both the PAENI and CMV 
mappings included all NPIH and PIH cases with such diagnoses. Using Fisher’s linear 
discrimination analysis, group comparisons by latitude and longitude mapping could significantly 
discriminate NPIH from PIH, or NPIH from PAENI, at the p < 0.01 level parametrically (Wilk’s 
lambda), and at the p= 0.03 and p=0.01 level respectively using a bootstrap method (see Figure 
S2). The number of cases mapped to a 0.1 x 0.1 degree grid (11 km per edge at the equator) 
are indicated with colored circles as 1, 2, or 3. 
 
Figure 2. Detection and typing of bacteria using 16S rDNA. A) Agarose gels showing 16S 
rDNA amplification products for PIH (red) and NPIH (blue), along with PCR positive (+) and 
negative (-) controls (green) and 10 separate extraction reagent controls (yellow). Brightness 
and contrast were adjusted for gels to maximize visibility of faint bands and smears. Asterisk (*) 
denotes lanes where faint non-specific amplification (smears) or bands of unexpected size were 
observed. All amplification products including non-specific amplifications were subjected to 
subcloning and sequencing. B) Paenibacillus qPCR quantification. C-D) Stacked bar relative 
abundance plots of (C) 16S V4 and (D) V1-V2 regions in microbial communities for the most 
dominant bacteria observed within (C) 16S positive samples from (B) and in (D) all 100 
samples. Star underneath PIH sample (C, D) highlights individual PIH sample with group B 
streptococcal infection. E) Scatterplot of cumulative sum scaling normalized Paenibacillus 
abundance for (abscissa) V4 16S sequencing of fresh frozen CSF samples and (ordinate) V1-
V2 16S sequencing of biological replicates from preserved CSF samples. F) Receiver-
operating-characteristic (ROC) curve using the number of Paenibacillus reads as the predictor 
for PIH or NPIH status. Area under the curve was 70.88% (95% DeLong CI = 60.61%-81.15%). 
Sensitivity and specificity are maximized at 47.5 reads in a given sample, consistent with the 
threshold employed of 50 reads. 
 
Figure 3. Viral detection, CT findings, thiamine levels, and infection status. A) Venn 
diagram of CMV detection using PCR on blood, and VirCap-Seq, RNA-Sequencing and PCR on 
CSF samples. B) Representative images of patients with NPIH or PIH, and CMV or 
Paenibacillus (Paeni) status. Both NPIH demonstrate Dandy-Walker cyst malformations (▲) 
without history or surgical findings reflective of prior infection. Note the presence in the 
Paenibacillus PIH cases of multiple loculations of CSF (✶), higher density fluid collections 
reflective of debris or blood within the CSF (▼), ectopic calcification within the brain (▢), and 
abscess formation (◯). C) CT scores stratified by clinical indication, PIH or NPIH, and D) as a 
function of CMV and Paenibacillus infection status, positive or negative respectively (see also 
Fig S6). E) Levels, in nmol/L, of thiamine diphosphate (TDP) in PIH (n=42) vs NPIH (n=19) 
cases. We observed that TDP levels are lower in PIH patients, (t-test, p<0.05). Boxplots display 
the median and upper and lower quartiles with whiskers forming the 1.5x the interquartile range. 
 
Figure 4. Clinical signs associate with Paenibacillus detection. A) Boxplots of (ordinate) 
log2 normalized Paenibacillus 16S rDNA abundance by age (categorized into 0-6 weeks and >6 
weeks) and by indication (see also Fig S6). B) Boxplots of (ordinate) CSF WBC count (cell/µL) 
by Paenibacillus status (+/-) and by indication (see also Fig S6). Cell count values less than 5 
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were mapped to 5. Cell count values greater than 250 were mapped to 250. C) Boxplots of 
(ordinate) corrected weight-for-age z-scores (WAZ), after calculating and subtracting excess 
CSF volume-for-age, by Paenibacillus status (+/-) and by indication. Boxplots display the 
median and upper and lower quartiles with whiskers forming the 1.5x the interquartile range. 
 
Figure 5. Whole genome sequencing and assembly of P. thiaminolyticus CSF isolate strain 
Mbale. From the cultured CSF samples, three isolates were identified as Paenibacillus (marked 
with asterisks in panel C). One isolate showed high 16S rDNA sequence identity to our V1-V2 
and V4 sequencing results thus making it the isolate of high interest. A) P. thiaminolyticus Mbale 
Gram stain from the chocolate agar subculture of the lytic anaerobic bottle at 1,000x 
magnification. Weak or negative Gram staining, despite a Gram positive cell structure, is 
characteristic of Paenibacillus species (55). B) To classify the P. thiaminolyticus clinical isolate, 
an extensive genome analysis was performed using both long-read and next generation 
sequencing along with optical mapping (GenBank Accession CP041404). The resulting draft 
circular genome shown was created using CGView which features coding sequences (CDS), 
tRNA, rRNA, phage insertions and GC content (53%). C) Phylogenetic tree of Paenibacillus spp. 
based on 40 marker genes. Cultured CSF isolates are indicated by yellow marks; the isolate 2033 
was renamed P. thiaminolyticus strain Mbale.  
 
Figure 6. Comparative murine histology of reference and Mbale strains of Paenibacillus 
thiaminolyticus. Murine model contrasting the virulence of the Mbale strain of P. 
thiaminolyticus vs the reference P. thiaminolyticus type strain NRRL B-4156T following 
intraperitoneal injection into C56BL/6J littermates, in comparison with saline control injections. 
No significant lesions are seen (top row) in the spleen of mice inoculated with normal saline 
(n=6) or reference strain (n=10). However, tingible body macrophage necrosis (black arrows) 
with intracytoplasmic apoptotic bodies were present in spleen of mice inoculated with the Mbale 
strain (9/10), suggestive of toxin induced apoptosis and a marked immune response with a high 
lymphocyte turnover. Likewise, the kidneys (middle row) of mice inoculated with normal saline 
or the reference strain had no significant lesions. In contrast, pyknotic nuclei (arrow head) of 
proximal tubule epithelial cells with cell sloughing and loss were observed within mice 
inoculated with the Mbale strain (9/10), indicative of acute tubular necrosis. In the brain (bottom 
row), there was no substantial evidence of infection-associated pathology (normal saline n=6/6, 
reference strain n=10/10, Mbale strain n=10/10). 
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Tables 
 
Table 1: Demographics and clinical characteristics of NPIH and PIH cohort.  
 
 
 
 
* n=98 
ǂ n=99 
 
Patient demographics and Clinical Characteristics. Comparison of demographic and clinical 
attributes between two groups: Postinfectious hydrocephalus (PIH, n=64) and non-
postinfectious hydrocephalus (NPIH, n=36). PIH patients were older (66 days vs 43 days, p 
<0.0001), had higher peripheral and cerebrospinal fluid (CSF) white blood cell (WBC) counts, 
and were more likely to be anemic (hemoglobin 10.7g/dL vs 13.0 g/dL, p<0.0001) compared 
with NPIH patients. Preoperative computed tomography (CT) scans were available for 98 
subjects. Of these, the PIH group was more likely to have a higher CT scan score reflective of 
brain abscess, calcifications, loculations and septations (p<0.0001). There were no significant 
differences in gender and human immunodeficiency virus (HIV) exposure frequencies between 
the groups. Continuous demographic variables were evaluated using the non-parametric 
Wilcoxon rank-sum (2-group comparisons) and Kruskal-Wallis (>2 groups) tests following 
Shapiro-Wilk's test for normality unless otherwise stated. Fisher’s exact test was performed for 
categorical variables. 
 
Characteristics All patients  
n=100 
 
PIH   
n=64 
 
NPIH  
n=36  
Age in days, mean (SD) 57 (24) 66 (17) 43 (27) 
Sex    
     Male (%) 51 (51) 35 (55) 16 (44) 
     Female (%) 49 (49) 29 (45) 20 (56) 
Peripheral blood WBC  
[1.0 x 103]/µL, mean (SD) 
10.3 (3.6) 11.0 (3.8) 8.8 (2.6) 
CSF WBC/µL, mean (SD)ǂ 30 (62) 45 (74) 5 (0.5) 
Hemoglobin g/dl, mean (SD) 11.5 (2.2) 10.7 (1.3) 13.0 (2.8) 
Hematocrit %, mean (SD) 36.8 (7.4) 34.1 (4.1) 41.6 (9.3) 
CT scan scoring*  
[no. and % in each category] 
   
     0 32 (33) 8 (25) 24 (69) 
     1 15 (15) 7 (11) 8 (23) 
     2 13 (13) 10 (16) 3 (8) 
     3 11 (11) 11 (17) 0 (0) 
     4 27 (28) 27 (43) 0 (0) 
HIV Exposure status [no. and %]    
     Yes 5 (5) 3 (5) 2 (6) 
     No 95 (95) 61 (95) 34 (94) 
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Microbial Characterization 
 
We describe in detail the wet lab and computational methods for microbial 
characterization as well as P. thiaminolyticus sequencing and assembly. 16S rRNA gene 
amplicon sequencing was employed to initially characterize the bacterial flora present in 
patients’ CSF for the characterization of dominant organisms and potential pathogen detection. 
16S rRNA amplicon sequencing is commonly used for microbial community characterization, 
including differential abundance analysis. However, a limitation to 16S rRNA amplicon 
sequencing is a lack of taxonomic resolution, where organisms are often only identifiable to the 
genus or family level.  
Through targeted amplicon sequencing we were able to characterize the flora and 
evaluate abundant and variable taxa within postinfectious hydrocephalus (PIH) cases and those 
differentially abundant between PIH cases and non-postinfectious hydrocephalus (NPIH) 
controls. Noticeably, we identified a Paenibacillus taxa both dominant and differentially 
abundant in PIH cases. Following detection, we isolated the organism, performed quantification 
using qPCR, biochemical testing, matrix-assisted laser desorption/ionization time-of-flight 
(MALDI-TOF) mass spectrometry, and marker gene taxonomy placement following genome 
assembly. All primers for these methods and their appropriate references are listed in Table S1.  
Extraction, Amplification, and Sequencing 
 
Below we present the extraction, amplification, and sequencing details for the fresh 
frozen and preserved CSF samples. 
 
Fresh Frozen CSF Samples 
Nucleic Acid Extraction of Fresh Frozen CSF Samples 
 
Prior to extraction, all tubes, columns, 0.1 mm and 0.5 mm glass beads (MoBio, CA, 
USA) and 1 mL extraction reagent aliquots were UV-irradiated twice at a distance of one inch 
from UV bulbs and at a setting of 3000 X 100 µJ/cm2 in a spectroLinker XL-1500 UV crosslinker 
(Spectronics Corporation, NY, USA). All of the kit extraction reagents (liquid) were aliquoted into 
2 mL tubes in a UV hood at a volume not exceeding 1 mL and were UV-irradiated as above. To 
control for any remaining contamination, ten extraction reagent controls (blank extractions, 
negative extraction controls) were also included. Nucleic acid from fresh frozen CSF was 
extracted using the QIAgen AllPrep DNA/RNA kit (QIAgen, MD, USA), with some modifications. 
Before extraction, 1.5 mL of CSF was first centrifuged at 5600 rpm for 10 minutes at 4°C to 
pellet all cells and 500 μL of supernatant was removed for viral analyses. To the remaining 1.0 
mL of CSF used for bacterial and fungal analysis, Buffer RLT with 0.01% ß-mercaptoethanol 
(600 mL and 700 ml, respectively) and 3 μL of DX reagents (QIAgen, MD, USA) were added 
along with 0.1 mm and 0.5 mm glass beads. Samples were disrupted in a Tissue Lyser 
(QIAgen, USA) for five minutes at 30 Hz followed by proteinase K digestion (6 mAU, Novagen, 
USA) done at 55°C for 30 minutes then all remaining steps were performed according to the 
manufacturer’s protocol. RNA and DNA concentration and purity were measured with a 
NanoDrop ND-100 spectrophotometer (NanoDrop Technologies, DE, USA) and stored at -80°C.  
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Bacterial V1-V4 16s rRNA gene and Fungal ITS2 amplification 
 
For PCR of both bacterial 16S rRNA and fungal ITS from fresh frozen CSF, 
consumables and prepared master mix (without primers) were UV-irradiated in a SpectroLinker 
XL-1500 UV crosslinker (3000 x 100 μj/cm2) prior to PCR setup. Once the prepared master mix 
was UV-treated, primers were added and a restriction digest was performed using Sau3AI at 
37°C for 30 minutes then chilled on ice for 5 minutes prior to template DNA being added. The 
following controls were used for all reactions: ten negative extraction control, three negative 
PCR controls (no template), and three positive PCR controls (DNA from human stool for 
bacteria or soil for fungi) included. Primers for 16S V1-V4 amplification were 27F.1 and 805R 
and primers for ITS2 amplification were ITS3F and ITS4R. Each 20 μL PCR reaction consisted 
of 1X Accuprime Buffer II, 0.75 units of Accuprime Taq DNA Polymerase High Fidelity (Life 
Technologies, Thermo Fisher, USA), 2.5 units of Sau3AI restriction enzyme, 400 nM of each 
primer and 5 μL of the extracted DNA. For 16S rRNA amplification, cycling conditions were as 
follows: 95°C for 5 min, followed by 40 cycles of 95°C for 30 s, 52°C for 1 min, 72°C for 1.5 min, 
followed by a final elongation step at 72°C for 7 min. For ITS2, cycling conditions were the same 
except the extension time at 72°C was 1 minute during cycling and the final extension at 72°C 
was 5 minutes. 
PCR products were run on a 1% agarose gel stained with GelGreen (Biotium, CA, USA). 
None of the extraction reagent controls or PCR reagent controls produced any signal on 
agarose gels. Visible bands were excised from the gel and purified using the QIAgen Gel 
Extraction kit according to manufacturer’s guidelines. Purified amplification products were 
ligated into the pGEM-T Easy vector (Promega Corporation, WI, USA) and inserts (at least 5 
clones per sample) were sequenced by Sanger sequencing (Genewiz, NJ, USA). 
V4 Illumina Sequencing of bacterial 16s rDNA 
 
DNA from fresh frozen CSF samples were amplified with composite barcoded primers 
targeting the V4 region of the bacterial 16S rRNA gene to generate libraries for Illumina MiSeq 
sequencing according to the Earth Microbiome Project standard protocol 
(http://www.earthmicrobiome.org/emp-standard-protocols/16s/) with minor modifications (56). 
The same decontamination techniques were employed as described above, except that two 
restriction enzymes were used to decontaminate PCR reagents in each reaction, 2 units each of 
Sau3AI and AciI. The same decontamination techniques were employed as described in full 
length 16S and ITS2 PCR amplifications techniques described above. The PCR cycling 
conditions were as follows: 94° C for 5 min, 40 cycles of 94°C for 20 s, 53°C for 25 s, 68°C for 
45 s and a final extension at 68°C for 10 min. Amplification products (2 μl) were run on a 1% 
agarose gel stained with GelGreen (Biotium, CA, USA) to verify amplification and negative 
reactions were verified on a BioAnalyzer. None of the extraction reagent controls or PCR 
reagent controls produced any signal on agarose gels or BioAnalyzer. PCR products were 
further purified using Ampure magnetic purification beads (Beckman Coulter Life Sciences). 
Ampure purified products were quantified with the Quanti-iT PicoGreen dsDNA Assay Kit 
(Invitrogen). Equimolar ratios of each sample were combined to create DNA pools of barcoded 
libraries for sequencing on an Illumina MiSeq. 
Real-time Quantitative PCR (qPCR) of Paenibacillus spp. from CSF 
 
Paenibacillus species specific qPCR was performed targeting 16S rDNA as previously 
described with modifications 
(https://www.sciencedirect.com/science/article/pii/S0022201111001108?via%3Dihub). For 
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absolute quantitation, DNA standards for Paenibacillus were constructed by PCR amplifying 
DNA obtained directly from Paenibacillus-positive CSF samples from this study. Purified 
amplification products were ligated into the pGEM-T Easy vector (Promega Corporation, WI, 
USA) and confirmed by Sanger sequencing. After verifying the plasmid insert sequence, 10-fold 
serial dilutions of plasmids were generated, ranging from 5 x 106 to 5 copies and were spiked 
with salmon sperm DNA (2.5 ng/μL). PCR efficiency for plasmid standards was above 90% with 
correlation coefficients ranging from 0.996 to 1, and sensitivity was 5 copies. Each 25 μL real-
time PCR reaction consisted of 1x TaqMan Universal PCR Master Mix (Applied Biosystems, 
Thermo Fisher Scientific, USA), 5 μL of fresh frozen CSF DNA and primers (PaeniF and 
PaeniR,250 nM) and a probe (PaeniProbe, 300 nM). An ABI Step-One Plus Real-time PCR 
system (Applied Biosystems) was used to perform all real-time PCRs using the following cycling 
conditions: initial denaturation at 95°C for 15 minutes followed by 45 cycles at 95°C for 15 sec 
and 60°C for 1.5 min. All samples were run in duplicate for each assay, and average copy 
number was calculated from duplicate reactions. Final results are presented as total 
Paenibacillus spp. 16S rDNA copies per mL of CSF.  
 
Preserved CSF Samples 
Nucleic Acid Extraction of Preserved CSF Samples 
 
Nucleic acid extractions on DNA/RNA Shield (Zymo, CA, USA) preserved samples were 
performed with reagents and consumables UV-treated in a PCR Workstation for 15 minutes. 
Each batch of extraction included a water control in which 500 μL of elution buffer was put 
through all extraction steps. DNA was extracted from shield samples using 500 μL of mixed 
sample using ZymoBIOMICS DNA Miniprep Kit (Zymo, CA, USA) with bead lysis using 0.15 mm 
and 0.5 mm ZrOBO beads in Bullet Blender (Next Advance, NY, USA) at high speed for 5 
minutes. After lysis, the manufacturer’s protocol was followed with proteinase K digestion and 
two elutions of 50 μL with elution buffer heated to 65°C. RNA was extracted from shield 
samples using TRIzol™ LS Reagent and Direct-zol™ RNA MiniPrep Plus kit. Samples were 
processed with two aliquots of 250 μL mixed with 750 μL of TRIzol™ LS Reagent. After bead 
lysis, 200 μL of chloroform was added, incubated at room temperature for 15 minutes then 
centrifuged at 12,000g for 15 minutes at 4°C. Once separated the aqueous layers from the two 
aliquots were put into the same tube. Then each organic layer was re-suspended in 400 μL of 
water and centrifuged again for 5 minutes. The 1.6 mL of aqueous phases were combined with 
1.6 mL of 100% ethanol and put through the Zymo-Spin™ IC Column twice and proceeded per 
manufacturer’s protocol.  
Bacterial 16S rRNA Library Prep and Sequencing with Primer-extension PCR  
 
Primer-extension PCR (PE-PCR) of the 16S rRNA V1-V2 region using primer 336R with 
M13 and 27F with previously described techniques by (57) with a few modifications. To control 
temperature appropriately the initial annealing step was done on the the Hybex microsample 
incubator (Scigene, CA, USA). To avoid any additional contamination, MolTaq 16S Mastermix 
(Molzym GmbH & Co Kg, Germany) was used for amplification following manufacturer’s 
protocol with the following optimized PCR cycling conditions: 35 cycles of 15 seconds at 95°C 
and 2 minutes at 60°C. All of the PE-PCR product was put into a 1x AMpure XP (Beckman 
Coulter) cleanup and eluted in 50 μL of 10 mM Tris pH 8. Library preparation was performed 
using the Hyper Prep Kit (KAPA Biosystems, USA) according to manufacturer's protocol, 
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adjusting adapter concentration based on total DNA input. Libraries were subsequently enriched 
with 7 cycles of PCR using the Library Amplification Module (KAPA Biosystems, USA). Libraries 
were quantified using Agilent Bioanalyzer DNA 1000 chip, pooled to an appropriate 
concentration and another 1x clean-up was performed. Sequencing was performed per the 
manufacturer’s protocol on Illumina’s Miseq using the 600 cycle v3 kit at 9 pM and 7% phiX with 
an aimed depth at 500k reads/sample.  
16S Analysis  
Below we present the analytical overview of the 16S analyses on our fresh frozen and 
preserved CSF samples. We first highlight the in silico comparison of V1-V2 and V4 amplicon 
regions for potential characterization based on Greengenes databases. Afterwards, we present 
our process for generating Operational Taxonomic Unit (OTU) count tables, annotation, 
differential abundance analysis, and comparison of diversity by sample type. 
In silico V1-V2 and V4 amplicon region characterization 
 
We define taxonomic resolution as the ability to differentiate between groups within a 
taxonomic level, for example differentiating between species within a genus. Taxonomic 
resolution can vary by clade and amplicon regions, though the extent to which it varies is not 
well characterized. Below in Section Comparison of V1-V2 and V4 we highlight the differential 
potential to speciate Paenibacillus taxa followed by the comparison of diversity levels and 
relationship to CSF cell count. 
We utilized metagenomeFeatures (58) and the MgDb annotation packages (59) to 
characterize taxonomic resolution for a specific clade and amplicon region, specifically for the 
Paenibacillus genus and V1-V2 and V4 regions using the Greengenes 13.5, 
greengenes13.5MgDb.us 
(http://bioconductor.org/packages/release/data/annotation/html/greengenes13.5MgDb.html). 
The number of sequences assigned to specific Paenibacillus species, range from 199 for 
Paenibacillus amylolyticus to 2 for Paenibacillus illinoisensis. Sequences only classified to the 
genus level, “Unassigned”, is the most abundant group, 2308. 
 16S rRNA amplicon sequencing taxonomic resolution for Paenibacillus species were 
compared by calculating within and between species pairwise distances. In order to differentiate 
between species, the pairwise distances within species amplicon sequences must be less than 
the between species distances. Additionally, the difference in amplicon sequence pairwise 
distances between and within species must be greater than the sequencing error rate to detect 
the difference. For our taxonomic resolution analysis we use in silico PCR to extract the V1-V2 
and V4 regions of the 16S rRNA sequences. We generated a pairwise distance matrix for the 
two regions and compared the within and between species pairwise distances using DECPIHER 
(https://decipher.sanger.ac.uk/). For our in silico PCR we used the bacterial portion of the PCR 
primers from Table S1 as:  
 
Region Forward Reverse 
V1-V2 27F - AGAGTTTGATCATGGCTCAG 336R - CACTGCTGCSYCCCGTAGGAGTCT 
V4 515F - GTGCCAGCMGCCGCGGTAA 806R - GGACTACHVGGGTWTCTAAT 
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For the V1-V2 and V4 analyses, only sequences with the appropriate expected amplicon 
lengths are extracted (318 bp and 252 bp for the V1-V2 and V4 regions respectively). The 
overall pairwise distance is greater between species than within species for the Paenibacillus 
genus. 
OTU Matrix Generation  
An open-reference OTU matrix was generated using Qiime version 1.9.1 (60) for all 
downstream analyses. In the process, reads were clustered using a 97% similarity cutoff with 
uclust version 1.2.22 and aligned using PyNAST v1.2.2 against a modified core Greengenes 
database vgg_13_8 (61) that included 16S references for three strains successfully isolated from 
clinical samples (see below). De novo OTUs were generated for unaligned reads. OTU centers 
were filtered due to chimeric detection using ChimeraSlayer (via microbiomeutil_r20110519) (62). 
OTU centers were assigned a taxonomic annotation using RDP Classifier v2.0.2 (63). Further 
taxonomic assignment for Paenibacillus of unannotated OTUs consisted of annotating centers 
against the NR database (updated with NCBI on Oct. 3rd, 2018) with BLAST. 
 
16S OTU Processing from Fresh Frozen CSF Samples 
Two thousand one hundred and five (2,105) OTUs were generated from the process 
described above. Of these, 658 passed chimera checking, were detected in more than five 
samples or represented at least 20 sequences in a single sample, and were included in further 
analysis. The number of OTUs per sample ranged from 51 to 296, with a median of 125 and an 
average of 137. The mean OTU size was 2328, ranging from 5 (by definition) to 736,735 (with 
median OTU size = 58 sequences). Among these, approximately 56% of OTU centers were 
annotated to the genus level using the Greengenes database, while others were annotated at 
family or higher levels. 
16S OTU Processing from Preserved CSF Samples 
 
Five thousand eighty-eight (5,088) OTUs were generated from targeted 16S rRNA 
amplicon sequencing. Of these, 1,767 passed chimera checking, were detected in more than five 
samples or represented at least 20 sequences in a single sample, and were included in further 
analysis. The number of OTUs per sample ranged from 22 to 429, with a median of 140 and an 
average of 156. The mean OTU size was 3,331, ranging from 5 (by definition) to 2,071,935 (with 
median OTU size = 126 sequences). Among these, approximately 66% of OTU centers were 
annotated to the genus level using the Greengenes database, while others were annotated at 
family or higher levels. 
 
Characterization of samples and clinical association 
Microbial Overview 
 
In processing samples, we prepared bar plots of the most abundant organisms present. 
Caution in interpretation of the background microbial diversity and community is necessary as 
CSF samples are low-biomass samples known to yield PCR and other sequencing artifacts 
(64). That being said, a number of patient samples yielded many reads from single taxa not 
known to associate with sequencing artifacts. Fig. 2C and 2D and Tables S3 and S4 highlight 
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the most abundant organisms from both preservative CSF (V1-V2 amplicon sequencing) and 
fresh frozen (V4 amplicon sequencing) samples, respectively. 
Similarity and diversity analysis 
 
The background microbial community and associations with clinical samples for the 
fresh frozen and preserved samples were compared. In particular, we compared Paenibacillus 
abundances for matching pairs of samples calculated by aggregating annotated OTU 
normalized counts and log-transforming, highlighting the similarity in abundance for various 
OTUs. We observed similar clustering of patients by Paenibacillus spp. V1-V2 and V4 OTUs 
(Fig. 2E, Fig. S5). 
Overall, diversity was lower in V4 samples potentially due to both the shorter V4 region 
and a different strategy of reagent contamination reduction, resulting in fewer OTUs. Diversity 
was inversely correlated with CSF cell count with the predominance of a single dominant 
organism in those samples as would be expected (Fig. S4B). The detection of Paenibacillus 
spp. presence in PIH samples was observed across multiple batches; in particular, sequencing 
and extraction batching was performed with a mix of PIH and NPIH samples to control for any 
artifacts. 
Differential abundance analysis 
 
Differential abundance and presence/absence analysis was performed to compare PIH 
and NPIH taxa abundance and presence. For differential abundance analysis normalized counts 
were aggregated to the genera level and a log-normal regression model was applied using 
limma (https://bioconductor.org/packages/release/bioc/html/limma.html) with abundance as the 
outcome variable and indication status as the independent variable. Counts were normalized 
using cumulative sum scaling and aggregated to the genera clade (65). For differential 
presence/absence testing we applied Fisher’s exact test on the presence/absence of each 
genus as defined by the presence of a positive count, also implemented within MetagenomeSeq 
(https://bioconductor.org/packages/release/bioc/html/metagenomeSeq.html). To account for 
multiple testing Benjamini and Hochberg’s false discovery rate was applied (66). 
 
Bacterial Isolate Whole Genome Sequencing and Assembly 
 
DNA Sequencing 
 
From cultured bacteria, high molecular weight DNA was prepared for optical mapping and 
both short and long read whole genome sequencing per the Prep Cell Culture DNA Isolation 
Protocol including the necessary Lysozyme digestion for bacterial cells (Bionano Genomics, CA, 
USA). PCR-free short read libraries were generated from 1 ug of E220 Focused Ultrasonicator 
(Covaris, USA) fragmented DNA, average insert size 400 bp with Hyper Prep Kit (KAPA 
Biosystems, USA). Final library pools were diluted to 10 pM, combined with 15% phiX, and 
sequenced to 10 million reads each with a MiSeq v3 600 cycle reagents. Long read sequencing 
library prep was performed using Hyper Prep kit (Kapa Biosystems, USA) and 1D Sequencing kit 
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(Oxford Nanopore Technologies, UK) following the manufacturer’s protocol. Sequencing was 
done using the MinION with the SQK-LSK108 SpotON flow cell following manufacturers protocol.  
 
Bacterial Genome Assembly 
 
Reads were aligned to hg38 using Bowtie 2 v2.3.4.3 to remove any spurious human reads. 
SPAdes v1.3.11 (67) was used for de novo scaffold generation using Illumina short read 
sequencing. To correct reads with scaffolds generated from Illumina short reads Pilon was 
employed (68). Basecalling and reads from MinIon were preprocessed using Albacore (Oxford 
Nanopore Technologies, https://nanoporetech.com/) Canu was used to assemble the MinIon 
long-reads (69). To generate the hybrid scaffold from optical mapping and corrected MinIon 
sequencing scaffolds the following Bionano Software was used: Bionano Access v1.3.0, Bionano 
Tools v1.3.8041.8044 and Hybrid Scaffold v10252018. 
 
Paenibacillus thiaminolyticus Identification and Characterization 
 
Below we present the various methodologies applied for characterization. We initially 
characterize the V1-V4 16S gene Sanger sequencing of identified Paenibacillus cases from 
fresh frozen CSF and generate a tree for relative relationship. Then we grew several isolates in 
culture, performed whole genome sequencing described earlier, and performed taxonomic 
placement using genomic marker genes.  
Phylogenetic Analyses of V1-V4 from Paenibacillus 
 
Paenibacillus spp. V1-V4 16S rDNA sequences from fresh frozen CSF were 
phylogenetically compared to each other. Analyses were conducted using MEGA7 (70). 
Sequence alignments were based on representative 16S rDNA sequences obtained from PCR 
amplification using 27F.1 and 805R primers and subcloning (as described above) from CSF of 
individual PIH patients in this study. Primer sequences were trimmed from the sequences. 16S 
rDNA sequences from Paenibacillus isolates and related species in Genbank were trimmed to 
the length of the sequences obtained from the CSF of PIH patients.  
The evolutionary history was inferred using the Neighbor-Joining method (71). The optimal 
tree with the sum of branch length = 1.20929307 is shown in Fig. S3. The percentage of replicate 
trees in which the associated taxa clustered together in the bootstrap test (500 replicates) are 
shown next to the branches (72). The tree is drawn to scale, with branch lengths in the same units 
as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary 
distances were computed using the Kimura 2-parameter method (73), and are in the units of the 
number of base substitutions per site. The analysis involved 39 nucleotide sequences. All 
ambiguous positions were removed for each sequence pair. There were a total of 750 positions 
in the final dataset. 
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Characterization for Organisms Recovered through Culture  
 
All 100 CSF samples were blindly cultured using six different media with varying 
inoculum and conditions listed in Table S8. If colonies grew on solid media, Gram stain and 
MALDI-TOF were performed to characterize the organism. For MALDI-TOF genus and species 
identification cutoff values were 1.7 and 2.0 respectively. If the BACTEC™ FX instrument 
flagged positive liquid culture bottles, a Gram stain and sub-cultures were performed as follows: 
1) Positive PEDS bottles were subcultured onto CHOC and incubated at 37°C, 5% CO2 for 5 
days 2) Positive ANA bottles were subcultured onto CHOC, anaerobic blood agar plate (ABAP) 
and incubated at 37°C, for 5 days in 5% CO2 (CHOC) or anaerobically (ABAP, Anoxomat 
System). For negative BACTEC™ liquid culture bottles gram stain was performed and blind 
cultures were done as follows: 1) For negative PEDSs bottles, subculture was done on 
CHOC/BAP and incubated at 37°C, 5% CO2 for 5 days 2) For negative ANA bottles, subculture 
was done on CHOC, anaerobic blood agar plate (ABAP) and incubated at 37°C, for 5 days in 
5% CO2 (CHOC) or anaerobically (ABAP, Anoxoimat Sysytem). Biochemical testing was 
performed using API 50 CH strip following manufacturers protocol. MALDI-TOF was used for 
initial screening of clinical isolates, but whole genome sequencing was used for definitive 
classification of all Paenibacillus isolates.  
Six CSF samples were positive for bacterial growth during initial incubation (within 14 
days of incubation), and the results summarized in Table S9. In addition, there were 4 positive 
blind cultures. Two of the blind ANA cultures were positive for Propionibacterium acnes, 2018 
and 2081, with MALDI-TOF scores of 2.28 and 2.26 respectively. A third ANA blind culture was 
positive and identified as Paenibacillus species with a MALDI-TOF score of 1.83. One of the 
blind PEDS cultures was positive and identified as Bacillus infantis with MALDI-TOF of 2.25. 
The API 50 CH system with API CHB/E media (BioMerieux) was used for biochemical 
characterization of the organisms. After a 48h incubation, both 2033 and NRRL B-4156 were 
identified as P. thiaminolyticus at a 99.9% confidence level (Table S10). 
 
Taxonomic Placement using Genomic Marker Genes 
 
Paenibacillus genomes, n=438, were downloaded from the Genbank ftp website (using 
the file ftp://ftp.ncbi.nlm.nih.gov/genomes/genbank/assembly_summary_genbank.txt, November 
2018). The 16S rRNA sequences of the 438 genomes were compared to the SILVA database 
(v132) (74) to filter the non-Paenibacillus genomes, by removing genomes with 16S rRNA 
identity to Paenibacillus lower than 97% on at least 300 nucleotide alignment length using 
BLASTN (75).  
Of the 438 genomes, 361 genomes were retained, due to fragmented 16S rRNA or not 
matching Paenibacillus taxa, and added with the pool of the newly sequenced clinical strains 
2033, 2006, 2009 and the genome Saccharibacillus sacchari DSM 19268 used to root the tree. 
For comparison, proteins in each genome were predicted using Prodigal (76), and 40 conserved 
phylogenetic marker proteins were extracted for each genome using the standalone software 
fetchMG v1.0 (77) and aligned using MUSCLE v3.8.425 (78). Duplicated markers in the genome 
were not included to reduce possible contaminant bias, and all genomes with fewer than 30 
markers detected were not included in the tree. The aligned markers were then concatenated to 
produce a single chimeric amino acid sequence.  
A phylogenetic tree was generated (Fig. 5C) using these chimeric concatenated 
sequences using FastTree v2.1.10 (79) using the options -gamma -pseudo -spr 4 -mlacc 3 -
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slownni to account for partial markers and increase exhaustiveness. The Newick FastTree file 
was then visualized using iTOL (80).  
The Paenibacillus isolation origins were manually explored using the NCBI and PATRIC 
website (81) and classified into 8 categories (animal, environment, human, milk, water, soil, plant, 
other) and considering rhizosphere isolation as a plant category. The isolation origin was then 
stored and structured into an iTOL TREE_COLORS file and display in the iTOL tree. 
Bacterial Antibiotic Sensitivity Testing 
 
A bacterial inoculum was prepared by emulsifying several well-isolated colonies from an 
overnight bacterial growth on agar plate into 3 ml of sterile water to achieve the turbidity of 0.5 
McFarland standard. S. aureus ATCC 29213 strain was used as quality control. A sterile swab 
soaked with inoculum suspension was used to inoculate a Mueller Hinton Agar with Blood plate 
(15x150mm). Plates were allowed to dry for 5 min to absorb excess moisture. Etest strips with 
antibiotics were placed on the plate within an equidistant pattern using a template. Plates were 
incubated at 37°C, 5% CO2 for 20 hours and mean inhibitory concentration (MIC) read and 
interpreted according to Clinical & Laboratory Standards Institute guidelines. The antibiotic 
resistance results are summarized in Table S11. 
 
Animal Model Virulence Testing 
For preparations of the bacterial culture for injection, bacteria grew for 18-24h on 
Trypticase Soy Agar (TSA II) with 5% sheep blood (BD) (SBA) plates, and were then 
suspended, washed once, and resuspended in sterile saline. Then, 10-fold serial dilutions were 
prepared in sterile saline, and 100 μL were plated on SBA. After 18-24h, growth was assessed 
and CFU/ml in the original inoculum were estimated from the colony counts on the first plate on 
which 10-100 colonies grew. 
 
Viral and Parasite Characterization 
 
We describe in detail the wet lab and computational methods for viral characterization. 
Parasite and viral PCR 
 
Detection of Zika virus (ZIKV), dengue virus (DENV), chikungunya virus (CHIKV), West 
Nile virus (WNV) and human RNAse P gene was done using CII-ArboViroPlex rRT-PCR assay 
(82). 
For cDNA synthesis of Trypanosoma brucei, Trypanosoma cruzi, Parvovirus, 
Enterovirus, Plasmodium, and Salmonella typhi, Superscript III (Invitrogen cat# 18080044) was 
used following the manufacturer’s protocol. The cDNA was used with the same assays done 
with DNA listed below.  
For testing of Plasmodium, Salmonella Typhi, Toxoplasmosis, Trypanosoma brucei, 
Trypanosoma cruzi, Parvovirus, and Enterovirus conventional PCR with DNA input was used 
using the primers and references in Table S1. Amplitaq Gold master mix (Life Technologies, cat 
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#4398881) was used per the manufacturer’s protocol with 25 µl volume with 1 µl of primers (15 
µM) and 1 µl of cDNA or DNA. For all cycling conditions, they were either unchanged from 
previous work referenced (Table S1) or they had the following modifications:  
1) Parvovirus at 95°C for 15 minutes, followed by 40 cycles of 95°C for 30 seconds, 
56°C for 30 seconds, 72°C for 30 seconds followed by 72°C for 5 minutes  
2) Enterovirus at 95°C for 15 minutes, followed by 15 cycles at 95°C for 30 
seconds, 65°C for 30 seconds (minus 1 degree per cycle), and 72°C for 30 
seconds, followed by 30 cycles of 95°C for 30 seconds, 50°C for 30 seconds, 
72°C for 30 seconds followed by 72°C for 5 minutes. 
In addition to conventional PCR, a TaqMan qPCR assay was used to detect Salmonella 
typhi and Plasmodium independently. Taqman 2x Universal PCR MasterMix (Thermofisher Cat# 
4304437) was used in 25 µl reactions with 5 µl of cDNA and 0.5 µl of 15 µM primers and probe. 
Thermal cycling and detection was done on the CFX96 Real-Time PCR Detection System (Bio-
Rad). Following cycling conditions were used for amplification: 95°C for 2 min, followed by 45 
cycles of qPCR at 95°C for 15 s and 60°C for 1 min. Fluorescence signal intensity was detected 
after completion of each qPCR cycle and data was collected using the CFX Manager™ 
Software. 
VirCapSeq-VERT 
For targeted viral detection, the capture technique VirCapSeq-VERT was 
performed as previously described (83). Low quality and poor complexity reads were 
filtered using PRINSEQ (v 0.20.2) and remaining reads were mapped with human host 
database using Bowtie 2 mapper 2.0.6 (84). Resulting reads were de novo assembled 
using MIRA (v4.0) assembler and homology search was performed on NCBI GenBank 
database (85). Both contigs and unique singletons from assembly were subjected to 
NCBI BLASTn, and unannotated sequences were further searched on non-redundant (nr) 
database using NCBI BLASTx. Based on BLASTn and BLASTx analysis viral sequences 
matching with Illumina reads and contigs, were downloaded from NCBI and used for 
mapping to recover partial or complete genomes. 
 
Viral RNA Sequencing 
Wet lab methods for RNA and sequencing 
 
RNA Libraries were made using TruSeq Stranded Total RNA with RiboErase (Illumina, USA) 
sample preparation. Illumina’s protocol was followed. Briefly, dependent on the extraction yield 
of RNA from CSF 1-100ng of RNA in 10ul were put into the prep, rRNA was depleted, cDNA 
and libraries were made and amplified for 15 cycles. The 130 libraries were pooled at 4nM, 
loaded for sequencing per the manufacturer’s protocol on the NovaSeq 6000 using the S2 
2x100 flow cell. 
PCR validation 
 
Given the sensitivity limitations of both VirCapSeq and RNASeq for detection of virus, 
two qPCR assays were used to both confirm and screen for CMV in all of the preserved CSF 
and blood samples. For initial screening, a protocol previously described was used with a few 
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optimizations (86). The reverse primer gB4 was modified to 5’- GGTGGTTGCCCAACAGGATT-
3’ due to off target human amplification and Quantitect SybrGreen Mastermix (Qiagen, USA) 
was used following manufacturers protocol for 10 μL reaction volumes and 2 μL DNA input with 
PCR and cycling conditions recommended by (87). A standard curve was generated from 10 
million to 1 million copies using a full length clone DNA of Homo cytomegalovirus gB (Sino 
Biologicals, Beijing, China) (88, 89). For confirmation of the initial screening all samples were 
ran using a TaqMan assay previously described (90). A standard curve was generated using a 
gBlock Gene Fragment of the UL54 region (IDT, Iowa, USA) from 10 million to 1 million copies. 
Technical replicates were evaluated in duplicate using each detection method. Samples were 
scored positive only if both replicates were positive in both assays. 
PCR confirmation for human papilloma virus (HPV) was performed using the L1 Major 
Capsid Protein. HotStarTaq (Qiagen, Cat # 203203) was used in 25 µl reactions following 
manufacturer’s protocol with 0.5 µl of 10 µM primers and 5 µl of DNA. For Sanger Sequencing, 
a 1x AMpure bead p (Beckman Coulter Life Sciences) clean-up was performed eluting in 10 µl, 
mixed with forward and reverse primers then sent to Genewiz (NJ, USA). In the original PCR 
the product contained human sequences so nested PCR was performed as well using the same 
procedure in the first PCR reaction with a 1:10 dilution of the original PCR product. Sequencing 
was performed as well in the same manner. A positive HPV gBlock (IDT, USA) of the L1 major 
capsid protein gene diluted in human DNA was used as a positive control.  
 
Computational analysis and pipeline 
 
We established an internal pipeline to detect human viral-specific reads within RNA-sequencing 
data. For quality pre-processing, reads and tails below a Phred score of 30 (91, 92), reads 
shorter than 75 bp, and residual adapter sequences are filtered using Trimmomatic (v. 0.36, 6) 
(93). Following pre-processing, unfiltered reads are aligned to hg38 with HISAT2 (v. 2.1.0) to 
eliminate any human-specific reads that may misalign to a manually curated virome reference 
database (84). Alignments are filtered by removing PCR duplicates, uniquely aligning reads 
(MAPQ score = 50), and removing tandem repeats with Picard (MarkDuplicates, v. 2.18.16, 8), 
Bedtools (v. 2.17.0, 10), Samtools, and Tandem Repeat Finder (v. 4.09, 9) to eliminate library 
generation bias and sequencing artifacts (Picard Tools, Broad Institute, 
http://broadinstitute.github.io/picard/) (94, 95). Finally, the number of virus-specific reads per 
viral strain within each sample are aggregated into a count matrix for downstream analysis.  
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Supplementary Figures  
 
Supplementary Figure 1: CT Scans. 
 
 
 
 
Supplementary Figure 1. Composite of CT scans from all patients grouped by postinfectious 
hydrocephalus (PIH, upper groupings) and non-postinfectious (NPIH, lower group) 
hydrocephalus. The PIH group is further clustered by Paenibacillus negative (left) and positive 
(right). Yellow and red stars implicate if a patient was PCR positive for CMV in the CSF and 
blood respectively. Note that one PIH Paenibacillus positive patient (2002) has a missing CT 
scan. Two other patients met criteria for a bacterial identification for a putative pathogen, 
indicated as group B Streptococcus (GBS) in a case that was also Paenibacillus positive, and 
one case with Bacillus sp. in the NPIH group. Two patients in the NPIH group were positive for 
Paenibacilli (Paeni) using V1-V2 analysis. Note that no patient in the NPIH group that was CMV 
positive in the blood had CMV detected in the CSF. 
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Supplementary Figure 2: Spatial Statistics. 
 
 
 
 
 
Supplementary Figure 2. Fisher’s canonical linear discrimination (LDA) contrasting the location 
of the groupings of cases shown in Fig. 1. Shown are Wilk’s lambda, W, reflecting the likelihood 
as the exponentiated sum of the log of the eigenvalues of the discriminant (96). W is chi-
squared distributed, and values smaller (greater) than the 95th or 99th percentile confidence 
limits (W95 or W99 respectively) are statistically significant (nonsignificant). To bootstrap the 
significance of the result, 10,000 random permutations of the group assignments into PIH vs 
NPIH were performed, and W recalculated. The probability, p, that the W of the LDA on the 
original unpermuted data was significantly different (smaller) than the permuted values is 
shown. The W from the data is shown as a red asterisk (*) on each histogram.  
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Supplementary Figure 3: Phylogenetic tree for 16S V1-V4 sequences 
 
 
 
Supplementary Figure 3.  
Phylogenetic tree for 16S V1-V4 sequences obtained from CSF of PIH patients (colored circles) 
and related isolates. The optimal evolutionary history was inferred using the Neighbor-Joining 
method (71). The percentage of replicate trees in which the associated taxa clustered together 
in the bootstrap test (500 replicates) are shown next to the branches (72). The tree is drawn to 
scale, with branch lengths in the same units as those of the evolutionary distances used to infer 
the phylogenetic tree. The evolutionary distances were computed using the Kimura 2-parameter 
method (73), and are in the units of the number of base substitutions per site. The analysis 
A.
+ + + - - -M RC
1
RC
2
RC
3
RC
4
RC
5
RC
6
RC
7
RC
8
RC
9
RC
10
16S PCR-Positive 16S PCR-Negative
PCR Controls Extraction Controls
PIH Cases
NPIH Cases
M
M
**
* **
*
*
**
* * **
B.
D.
C.
E.
Pa
en
ib
ac
ill
us
sp
p.
16
S
 c
op
ie
s/
m
L 
C
S
F
Redo this figure
To show the 27
True Paeni Positive
PIH samples and
Compare PIH-Pos
To PIH-Neg. Not sure CMV
makes sense in this figure
Or add this to a later figure
After CMV results are discussed.
107
106
105
104
103
102
101
100
PIH and NPIH Cases
% Relative Abundance
P
IH
C
as
es
N
P
IH
C
as
es
s_Paenibacillus lentimorbus
s_Paenibacillus alvei
g_Streptococcus
g_Streptococcus;s_
g_Bacteriodes
g_Staphylococcus
f_Comamonadaceae
o_Clostridiales
g_Bacillus
s_Burkholderia bryophila
other
All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted August 4, 2020. ; https://doi.org/10.1101/2020.08.03.20167544doi: medRxiv preprint 
17 
involved 39 nucleotide sequences. All ambiguous positions were removed for each sequence 
pair. There were a total of 750 positions in the final dataset.  
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Supplementary Figure 4: Further analysis of the microbial 16S community 
 
 
 
Supplementary Figure 4. Further analysis of the microbial 16S community. A) Receiver-
operating-characteristic curve using Paenibacillus cumulative sum scaling (CSS) normalized 
abundance as the predictor for PIH or NPIH status. Area under the curve was 73.09% (95% 
DeLong CI = 63.19%-82.99%). B) Scatterplot of (y-axis) log2 normalized Paenibacillus 16S 
abundance by (x-axis) Shannon diversity estimates. C) Classical multidimensional scaling on 
the Bray-Curtis distance matrix of 16S abundances. 
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Supplementary Figure 5: OTU Heatmaps. 
 
 
 
Supplementary Figure 5.  
 
Log-transformed number of reads for each Operational Taxonomic Unit (OTU) annotated to 
the Paenibacillus genus. OTUs were subset to only those annotated to the Paenibacillus genus. 
The columns represent samples with hydrocephalus status (PIH/NPIH) and Paenibacillus 
positivity as defined by at least 50 reads within the respective dataset. Both the V1-V2 (left) and 
V4 (right) 16S sequencing have two dominant OTU sequence centers that are most represented 
among the positive Paenibacillus (green) patients with the exception of an NPIH positive case 
that clusters separately in the V1-V2 sequencing cohort. These OTU centers have high 
sequence similarity to the P. thiaminolyticus Mbale clinical isolate while not having sequence 
similarity ≥ 97% to the other two Paenibacillus isolates. Specifically, the two most abundant 
OTU sequence centers in V4, 99373 and 151968, align at 100% and 99.6% respectively along 
with three other less abundant but present centers OTUs 545572, 1144371, and 494140 that 
align at >99%. For V1-V2, OTU 168 and 624 dominate the signal and align to the clinical isolate 
at 100% and 97% respectively. 
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Supplementary Figure 6: qPCR vs Age, CT Score, and Cell Counts. 
 
 
 
 
 
Supplementary Figure 6.. Distribution of Paenibacillus quantity as determined by qPCR in CSF 
by age (A) and CT score (B). Quantity of Paenibacillus in CSF from PIH patients with >5 cells/µl 
CSF compared to PIH patients with ≤ 5 cells/µl CSF (C). Relationship between Paenibacillus 
quantity in CSF and CSF cell counts (cells/µl) in PIH patients with quantifiable Paenibacillus by 
qPCR (D). Relationship between Paenibacillus quantity in CSF and WBC counts in blood 
(cells/µl) in PIH patients with quantifiable Paenibacillus by qPCR (E). The linear regression line 
estimated by a univariate model for CSF cells (D) or WBC counts (E) with Paenibacillus quantity 
as the primary covariate is shown (solid line in D, E). p-values shown were derived from the 
Mann-Whitney U test (A, C), the Kruskal-Wallace test (B) and univariate linear regression (D, 
E). The estimated increase in CSF cells or WBC counts for one log10 fold increase in 
Paenibacillus quantity and associated 95% CI is indicated (slope and 95% CI, D and E). 
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Supplementary Figure 7: CT Score Frequencies. 
 
 
 
Supplementary Figure 7. A) CT scores as a function of CMV infection status, positive or 
negative, in CSF. CT score status further stratified by clinical indication, PIH or NPIH, and 
whether CSF 16S sequencing was positive for P. thiaminolyticus, and whether CMV was 
positive or negative in CSF. B) CT scores as a function of CMV infection status, positive or 
negative, in blood. CT score status further stratified by clinical indication, PIH or NPIH, and 
whether CSF 16S sequencing was positive for P. thiaminolyticus, and whether CMV was 
positive or negative in blood. 
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Supplementary Tables 
 
Supplementary Table 1: Primer Table. 
 
Organism Target Primer Sequence Nucleic 
Acid 
Publication 
Plasmodium 18S Plasmo 1 GTTAAGGGA
GTGAAGACG
A TCAGA 
DNA (97) 
Plasmo 2 AACCCAAAG
ACTTTGATTT
CTCATAA 
Plasmodium 18S PlasF TTTCTGACC
TATCAGCTT
TTGATGTT 
RNA Unpublished 
PlasR GCTCCCTCT
CCGGAATCG 
PlasProbe CTAACATGG
CTATGACGG
GT 
Toxoplasmosis B1 gene Toxo 
Oligo 2 
TAATACGAC
TCACTATAG
GGTGCATAG
GTTGCAGT 
CACTG 
DNA (98)  
Toxo 
Oligo 4 
TCTT 
TAAAGCGTT
CGTGGTC 
Trypanosoma 
brucei  
Expression 
site 
associated 
protein-6 
ESAGF1 GCGTTAGCA
GCAGCTGCA
GCTGGG 
RNA and 
DNA 
(99) 
 
mycR CCCAAGTCC
TCTTCAGAA
ATGAGC 
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Trypanosoma 
cruzi 
  
Major 
repetitive 
element 
 TCZ1 dCGAGCTCT
TGCCCACAC
GGGTGCT 
 DNA (100) 
TCZ2 dCCTCCAAG
CAGCGGATA
GTTCAGG 
Salmonella 
typhi 
Flagella 
gene 
StyphiF ACCATCGGG
CTTTAAGGT
TGCC 
RNA Unpublished 
StyphiR GCGCCCAGA
TGGTACTCA
AACC 
StyphiPro
be 
TCGCGCTTC
CTACCGGGC
T 
Parvovirus B19 NS1 Parvo-
NS1-F 
TAGTGGTGG
TGAAAGCTC
TGA 
RNA Unpublished 
  
Parvo-
NS1-R 
TCCGACAGA
TGATTCTCC
TGA 
Enterovirus 5’UTR Hiro-UTR-
fwd-1 
GGTCAAGCA
CTTCTGTTT
CCC 
RNA Unpublished 
EV-UTR-
L541 
GAAACACGG
WCACCCAAA
GTASTCG 
Unpublished 
Human 
Papilloma Virus 
Major 
Capsid 
Protein L1 
RT-HPV-
5034-F 
GTAGCACTC
CCAATGAAA
GGTC 
DNA Unpublished 
  
RT-HPV-
5251-R 
GTCTCTGTC
TGGAGGSTC
TTCA 
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Human 
Papilloma Virus 
Major 
Capsid 
Protein L1 
MCP-
Nested-
Fwd 
CGGTCATTA
ACCAATAGA
CG 
DNA Unpublished 
MCP-
Nested-
Rev 
AAATCTTAC
CAATCTAGA
GGGCTG 
Human Herpes 
Virus 5 (CMV) 
UL54 CPOL-
F720 
GCTGACGCG
TTTGGTCAT
C 
DNA (90) 
CPOL-
R780 
ACGATT CAC 
GGA GCA 
CCAG 
CPOL-
741FAM 
TCGGCGGAT
CACCACGTT 
CG 
Human Herpes 
Virus 5 (CMV) 
UL55 gB2 ACGACCCGT
GGTCATCTT
TA 
DNA (86) 
gB4-
modified 
GGTGGTTGC
CCAACAGGA
TT 
Paenibacillus 
spp. 
16S PaeniF CAGGGAAGA
ACGCTATGG
A 
DNA (101) 
PaeniR CGATGCGAC
CCGGAGTT 
PaeniProb
e 
FAM-
TGTTCCATA
GGTGACGGT
ACCT-MGB 
Prokaryotes V1-V4 16S 
rRNA 
27F.1 AGRGTTTGA
TCMTGGCTC
AG 
DNA (102) 
805R GACTACCAG
GGTATCTAA
T 
(103) 
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Prokaryotes V1-V2 16S 
rRNA 
27F AGAGTTTGA
TCMTGGCTC
AG 
DNA (104) 
336R_M1
3 
CAGGGTTTT
CCCAGTCAC
GACACTGCT
GCSYCCCGT
AGGAGTCT 
(105) (modified) 
M13 CAGGGTTTT
CCCAGTCAC
GAC 
na 
Prokaryotes V4 16S 
rRNA 
515F AATGATACG
GCGACCACC
GAGATCTAC
ACTATGGTA
ATTGTGTGC
CAGCMGCC
GCGGTAA 
DNA (56) 
806R CAAGCAGAA
GACGGCATA
CGAGATXXX
XXXXXXXXX
AGTCAGTCA
GCCGGACTA
CHVGGGTW
TCTAAT 
(56) 
Fungi ITS2 ITS3F GCATCGATG
AAGAACGCA
GC 
DNA (104) 
ITS4R TCCTCCGCT
TATTGATAT
GC 
 
 
Supplementary Table 1. Primer table for all PCR to identify microbiological DNA or RNA 
present in the CSF or Blood. 
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Supplementary Table 2: Fresh Frozen PCR and Sequencing. 
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Sample 
Number 
Group cPCR 16S 
V1-V4 
amplification 
cPCR 16S V1-V4 
(Cloning/Sequencing 
Results) 
Paenibacillus 
genus-specific 
qPCR (16S 
copies/mL 
CSF) 
V4 MiSeq 
(Dominant taxa) 
Assay 
Concordance 
(# Assays 
demonstrating 
Paenibacillus) 
2002 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
2.33E+05 Paenibacillus sp. 3 
2003 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
5.07E+04 Paenibacillus sp. 3 
2006 PIH Negative no amplification 0 no amplification 0 
2007 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
5.59E+06 Paenibacillus sp. 3 
2008 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
1.79E+05 Paenibacillus sp. 3 
2009 PIH Negative no amplification 0 no amplification 0 
2012 PIH Negative no amplification 0 no amplification 0 
2014 PIH Negative no amplification 0 no amplification 0 
2015 PIH Negative no amplification 0 no amplification 0 
2017 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
1.49E+06 Paenibacillus sp. 3 
2018 PIH Negative no amplification 0 no amplification 0 
2020 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
3.63E+03 Paenibacillus sp. 3 
2023 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
3.23E+06 Paenibacillus sp. 3 
2024 PIH Negative no amplification 0 no amplification 0 
2025 PIH Negative no amplification 0 no amplification 0 
2026 PIH Negative no amplification 1.41E+04 no amplification 1 
2027 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
5.16E+04 Paenibacillus sp. 3 
2028 PIH Positive Paenibacillus alvei 0* Paenibacillus 
alvei 
2 
2029 PIH Negative no amplification 0 no amplification 0 
2030 PIH Negative no amplification 0 no amplification 0 
2032 PIH Negative no amplification 0 no amplification 0 
2033 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
5.67E+05 Paenibacillus sp. 3 
2035 PIH Negative no amplification 0 no amplification 0 
2036 PIH Negative no amplification 0 no amplification 0 
All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted August 4, 2020. ; https://doi.org/10.1101/2020.08.03.20167544doi: medRxiv preprint 
28 
2039 PIH Negative no amplification 0 no amplification 0 
2040 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
4.23E+05 Paenibacillus sp. 3 
2041 PIH Negative no amplification 0 no amplification 0 
2043 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
5.68E+06 Paenibacillus sp. 3 
2044 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
2.20E+02 Paenibacillus sp. 3 
2045 PIH Negative no amplification 0 no amplification 0 
2046 PIH Positive Streptococcus 
agalactiae 
0 Streptococcus 
sp. 
0 
2048 PIH Negative no amplification 2.91E+01 no amplification 1 
2050 PIH Positive Alkanindiges sp. 0 no amplification 0 
2051 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
1.33E+06 Paenibacillus sp. 3 
2052 PIH Negative no amplification 0 no amplification 0 
2053 PIH Negative no amplification 0 no amplification 0 
2054 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
5.22E+04 Paenibacillus sp. 3 
2055 PIH Negative no amplification 0 no amplification 0 
2056 PIH Negative no amplification 0 no amplification 0 
2057 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
2.22E+04 Paenibacillus sp. 3 
2059 PIH Negative no amplification 0 no amplification 0 
2061 PIH Negative no amplification 0 no amplification 0 
2062 PIH Negative no amplification 0 no amplification 0 
2065 PIH Negative no amplification 0 no amplification 0 
2066 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
9.22E+04 Paenibacillus sp. 3 
2068 PIH Negative no amplification 0 no amplification 0 
2071 PIH Negative no amplification 0 no amplification 0 
2072 PIH Negative no amplification 9.46E+05 no amplification 1 
2073 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
1.37E+05 Bacteroides and 
Paenibacillus sp. 
3 
2074 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
6.19E+05 Paenibacillus sp. 3 
2076 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
1.56E+04 Paenibacillus sp. 3 
All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted August 4, 2020. ; https://doi.org/10.1101/2020.08.03.20167544doi: medRxiv preprint 
29 
2078 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
7.64E+05 Paenibacillus sp. 3 
2079 PIH Negative no amplification 0 no amplification 0 
2080 PIH Negative no amplification 0 no amplification 0 
2081 PIH Negative no amplification 0 no amplification 0 
2086 PIH Negative no amplification 0 no amplification 0 
2087 PIH Negative no amplification 0 no amplification 0 
2088 PIH Negative no amplification 0 no amplification 0 
2089 PIH Positive Mixed taxa 2.33E+03 Staphylococcus 
and Paenibacillus 
sp. 
2 
2090 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
2.93E+05 Paenibacillus sp. 3 
2091 PIH Negative no amplification 0 no amplification 0 
2093 PIH Negative no amplification 0 no amplification 0 
2096 PIH Positive Paenibacillus 
thiaminolyticus or 
popilliae 
2.79E+03 Paenibacillus sp. 3 
2097 PIH Positive Mixed taxa 0 Streptococcus 
sp. 
0 
2001 NPIH Negative no amplification 0 no amplification 0 
2004 NPIH Negative no amplification 0 no amplification 0 
2005 NPIH Negative no amplification 0 no amplification 0 
2010 NPIH Negative no amplification 0 no amplification 0 
2011 NPIH Negative no amplification 0 no amplification 0 
2013 NPIH Negative no amplification 0 no amplification 0 
2016 NPIH Positive Clostridiales sp. 0 Burkholderia sp. 0 
2019 NPIH Negative no amplification 0 no amplification 0 
2021 NPIH Negative no amplification 0 no amplification 0 
2022 NPIH Negative no amplification 0 no amplification 0 
2031 NPIH Negative no amplification 0 no amplification 0 
2034 NPIH Negative no amplification 0 no amplification 0 
2037 NPIH Negative no amplification 0 no amplification 0 
2038 NPIH Negative no amplification 0 no amplification 0 
2042 NPIH Negative no amplification 0 no amplification 0 
2047 NPIH Negative no amplification 0 no amplification 0 
2049 NPIH Negative no amplification 0 no amplification 0 
2058 NPIH Negative no amplification 0 no amplification 0 
2060 NPIH Negative no amplification 0 no amplification 0 
2063 NPIH Positive Bacillus sp. 0 Bacillus sp. 0 
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Supplementary Table 2. Summary of results based on conventional PCR (cPCR) using 16S 
V1-V4 primers with cloning and sequencing, Paenibacillus genus-specific qPCR, and V4 MiSeq 
on DNA obtained from fresh frozen CSF from each PIH (n=64) and NPIH (n=36) subject and 
concordance between the three assays for the presence of Paenibacillus. 
  
2064 NPIH Negative no amplification 0 no amplification 0 
2067 NPIH Negative no amplification 0 no amplification 0 
2069 NPIH Negative no amplification 0 no amplification 0 
2070 NPIH Positive Mixed taxa 0 Clostridiales sp. 0 
2075 NPIH Negative no amplification 0 no amplification 0 
2077 NPIH Negative no amplification 0 no amplification 0 
2082 NPIH Negative no amplification 0 no amplification 0 
2083 NPIH Negative no amplification 0 no amplification 0 
2084 NPIH Negative no amplification 0 no amplification 0 
2085 NPIH Negative no amplification 0 no amplification 0 
2092 NPIH Negative no amplification 0 no amplification 0 
2094 NPIH Negative no amplification 0 no amplification 0 
2095 NPIH Negative no amplification 0 no amplification 0 
2098 NPIH Negative no amplification 0 no amplification 0 
2099 NPIH Negative no amplification 0 no amplification 0 
2100 NPIH Negative no amplification 0 no amplification 0 
* Note, genus-specific qPCR primers for Paenibacillus would not be expected to amplify Paenibacillus alvei due to 
substantial mismatches in the primer binding sites of this species 
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Supplementary Table 3: Differential Abundance. 
 
Taxa logFC AveExp t p.value adjusted 
p.value 
B 
g__Paenibacillus 4.8292 8.0664 4.1496 0.0001 0.0111 1.5032 
g__Tepidimonas 3.0803 8.4413 3.4537 0.0008 0.0645 -0.6682 
g__Rothia 2.1504 1.9001 2.9372 0.0041 0.2178 -2.0791 
g__Micrococcus 1.6369 1.6634 2.4435 0.0163 0.6476 -3.2479 
g__Anaerococcus -1.2173 1.1405 -2.1411 0.0347 0.6806 -3.8703 
g__Anoxybacillus 1.0416 0.7633 2.0259 0.0454 0.6806 -4.088 
g__Moraxella -0.4952 0.1783 -1.914 0.0585 0.6806 -4.2887 
g__Actinomycetospora -0.4519 0.1627 -1.8299 0.0702 0.6806 -4.4328 
g__Gordonia 0.4937 0.4333 1.8238 0.0712 0.6806 -4.4428 
no_match -0.6577 12.7805 -1.8053 0.074 0.6806 -4.4736 
 
 
Supplementary Table 3. Differential abundance. Statistical results from 16S Differential 
Abundance Testing using V1-V2. Counts were aggregated to the genera level and a log-normal 
regression model was applied using limma (106) with abundance as the outcome variable and 
indication status as the independent variable. The ten genera with the highest B-statistic are 
reported. 
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Supplementary Table 4: Viral Results. 
 
  
Viral Summary 
Results 
VirCapSeq-VERT RNA-Seq PCR 
PIH 
(64) 
NPIH 
(36) 
PIH 
(64) 
NPIH 
(36) 
PIH (n) NPIH (n) 
Virus CSF CSF Blood CSF Blood CSF 
Human Herpesvirus 
5 (CMV) 
8  0 4 0 18 (64) 8 (64) 9 (35) 0 (36) 
Human 
Papillomavirus 
8 8  0  0  0 (11) 0 (11)  0 (8) 0 (8) 
Human Pegivirus / 
GBV-C 
3 1  0  0         
Human Herpesvirus 
6A 
1  0  0  0         
Human Herpesvirus 
6B 
1 2  0  0         
Human Rotavirus 1 1  0  0         
Torque Teno Virus 2 1  0  0         
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Human Parvovirus 
(B19/V9) 
1  0  0  0         
Norovirus 1  0  0  0         
Merkel Cell 
Polyomavirus 
 0 1  0  0         
Circovirus  0 1  0  0         
No Viral Reads 43 21 60 36         
 
 
Supplementary Table 4. Summary of viral analysis using VirCapSeq, PCR, and RNAseq. 
All 100 CSF samples were tested with VirCapSeq-VERT and RNASeq. VirCapSeq-VERT 
detected evidence of 12 viruses present across 36 samples and RNASeq detected Humans 
Herpesvirus 5 (CMV) in 4 samples. The only virus that was confirmed through PCR at high 
abundance in our samples was CMV, for which we confirmed 5 of the 8 VirCapSeq-VERT 
samples and 3 of the 4 RNASeq positive CSF samples. CMV was only identified in the CSF 
from CMV blood positive PIH cases. PCR testing was performed for CMV and HPV. 
  
All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted August 4, 2020. ; https://doi.org/10.1101/2020.08.03.20167544doi: medRxiv preprint 
34 
Supplementary Table 5: Demographics with and without Paenibacillus. 
 
 
* n=98 
ǂ n=99 
 
Supplementary Table 5. Comparison of demographic and clinical attributes between three 
groups: NPIH, PIH patients infected with Paenibacillus and PIH patients without Paenibacillus. 
PIH patients with Paenibacillus were more likely to be younger compared to those without 
Paenibacillus but there were no gender differences between these three groups. To investigate 
if the biomarkers of active inflammation were different between the three groups, we analyzed 
white blood cell (WBC) count. WBC from peripheral blood and CSF were significantly higher in 
the PIH group with Paenibacillus compared to other groups. However, the Paenibacillus group 
did not show a difference in hemoglobin or hematocrit concentration when compared to PIH 
without Paenibacillus. Preoperative computed tomography (CT) scans were available for 98 
patients (98%). Of these, patients in the PIH group with Paenibacillus were more likely to have a 
higher CT scan score indicative of brain abscess, calcifications, loculations and septations 
(p<0.0001). However, there were no significant differences in gender and human 
Characteristics All 
patients 
n=100 
PIH with 
Paenibacillus 
n=38 
PIH without 
Paenibacillus 
n=26 
NPIH 
n=36 
Age in days, mean (SD) 57 (24) 59 (17) 75 (11) 43 (27) 
Sex     
     Male (%) 51 (51) 21 (55) 14 (54) 16 (44) 
     Female (%) 49 (49) 17 (45) 12 (46) 20 (56) 
Peripheral blood WBC  
[1.0 x 103]/µL, mean (SD) 
10.2 (3.6) 12 (4) 9.8 (3) 8.8 (2.6) 
     Lymphocytes %  56.8 (12.1) 65.4 (8.8) 59.3 (12.0) 
     Granulocytes % (SD)  33.6 (13.6) 26.0 (8.4) 31.1 (10.9) 
CSF WBC/µL, mean (SD)ǂ 30 (62) 71 (87) 5 (0) 5 (0.5) 
     Glucose mg/dL (SD)  32.4 (16.8) 30.5 (7.6) 38.8 (13.5) 
     Protein mg/dL (SD)  166.2 (108.3) 70.4 (60.4) 37.7 (33.1) 
Hemoglobin g/dl, mean (SD) 11.5 (2.2) 10.8 (1.3) 10.5 (1.3) 13.0 (2.8) 
Hematocrit %, mean (SD) 36.8 (7.4) 34.4 (4.1) 33.6 (4.2) 41.6 (9.3) 
CT scan scoring*  
[no. and % in each category] 
    
     0 32 (33) 1 (3) 7 (27) 24 (69) 
     1 15 (15) 2 (5) 5 (19) 8 (23) 
     2 13 (13) 5 (14) 5 (19) 3 (9) 
     3 11 (11) 7 (19) 4 (16) 0 (0) 
     4 27 (26) 22 (59) 5 (19) 0 (0) 
HIV Exposure status [no. and %]     
     Yes 5 (5) 1 (3) 2 (8) 2 (6) 
     No 95 (95) 37 (97) 24 (92) 34 (94) 
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immunodeficiency virus (HIV) frequency between the groups. Continuous demographic 
variables were evaluated using the non-parametric Wilcoxon rank-sum (2-group comparisons) 
and Kruskal-Wallis (>2 groups) tests following Shapiro-Wilk's test for normality, unless 
otherwise stated. Fisher’s exact test was performed for categorical variables.  
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Supplementary Table 6: Paenibacillus vs CMV. 
 
CSF PIH NPIH  Blood CSF PIH NPIH 
CMV - Paeni + 32 2  CMV - Paeni + 28 1 
 
Paeni - 24 34   Paeni - 18 25 
CMV + Paeni + 6 0  CMV + Paeni + 10 1 
 
Paeni - 2 0   Paeni - 8 8 
 
 
 
Supplementary Table 6. Contingency tables for the prevalence of Paenibacillus positivity 
defined by 16S and the detection of CMV found in CSF or blood respectively. Interestingly, we 
did not observe any CMV positive CSF in NPIH samples. 
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Supplementary Table 7: CT Score vs CMV. 
 
Loculations\CMV CSF Negative Positive Totals 
Negative 43 1 44 
Positive 48 6 54 
Totals 91 7 98 
    
Debris\CMV CSF Negative Positive Totals 
Negative 48 1 49 
Positive 43 6 49 
Totals 91 7 98 
    
Calcification\CMV CSF Negative Positive Totals 
Negative 47 1 48 
Positive 44 6 50 
Totals 91 7 98 
    
Abscess\CMV CSF Negative Positive Totals 
Negative 67 2 69 
Positive 24 5 29 
Totals 91 7 98 
 
 
Supplementary Table 7. Table of CT score composite features cross tabulated with CMV CSF 
status. Within the CMV negative population, 26%, 48%, 53%, and 47% had signs of abscesses, 
calcifications, loculations and debris respectively. In contrast the CMV positive population, albeit 
with small numbers, 71% and 86% of patients had signs of abscesses or calcifications, 
loculations, or debris respectively. Controlling for Paenibacillus presence in an ordinal logistic 
regression did not demonstrate a significant odds ratio relating CMV positivity to elevated CT 
scan scores OR (95% CI) = 3.30 (0.52, 29.66). 
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Supplementary Table 8: Culture Media. 
 
Media Volume of inoculum (µl) Conditions Duration (Days) 
CHOC 100 37°C, 5% CO2 7 
BAP 100 37°C, 5% CO2 7 
MAC 100 37°C, 5% CO2 7 
CMG 200 37°C, Ambient air 14 
PEDS 250 37°C, BACTEC instrument 14 
ANA 50 37°C, BACTEC instrument 14 
 
 
Supplementary Table 8. Detailed description of the six different culture media with the 
respective inoculum volume, conditions and duration of culture. BBLTM Chocolate Agar (CHOC), 
BBLTM Sheep blood Agar (BAP), BBLTM MacConkey Agar (MAC), Chopped Meat Glucose Broth 
(CMG), BD BACTEC™ Peds Plus™ medium (PEDS), BD BACTEC™ Lytic Anaerobic medium 
(ANA).  
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Supplementary Table 9: Culture Results. 
 
 
Sample 
Positive 
Culture 
Gram 
Stain 
Subculture 
(morphologies) 
Maldi-TOF ID MALDI-
TOF 
Score 
2009 ANA GNR None Paenibacillus amyloliticus 1.43 
2009 CMG,CHOC GPR N/A Propionibacterium acnes 2.08 
2033 ANA GVR Yes (2) Paenibacillus thiaminolyticus 
Paenibacillus thiaminolyticus 
2.3 
1.38 
2051 CMG GNR/GPR Yes (3) Bacillus okuhidensi 
Bacillus halodurans 
Propionibacterium acnes 
2.29 
2.16 
2.20 
2086 ANA GPR Yes (1) Propionibacterium acnes 2.22 
2086 CMG GPR/GNR None Propionibacterium acnes 
Dermobacter hominis 
2.22 
1.83 
2092 ANA GPR Yes (1) Propionibacterium acnes 2.15 
2084 ANA GPC Yes (1) Streptococcus salivarius 1.96 
2006 ANA (blind) GNR Yes (1) Paenibacillus spp. 1.83 
2025 PED (blind) GNR Yes (1) Bacillus infantis 2.25 
2018 ANA (blind) GPR Yes (1) Propionibacterium acnes 2.28 
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2081 ANA (blind) GPR Yes (1) Propionibacterium acnes 2.26 
 
Supplementary Table 9. The culture and subculture results from 100 fresh frozen CSF patient 
samples. All 100 fresh frozen CSF samples were inoculated in 6 different media outlined in 
Table S8 and subcultured. Successful subcultures and solid media cultures were tested with 
MALDI-TOF for identification using 1.7 and 2.0 cut offs for genus and species identification 
respectively. For samples that were unable to grow on solid media MALDI-TOF was performed 
on the liquid culture. Further, negative liquid cultures were blindly subcultured (blind) and 
positive cultures were also tested with MALDI-TOF. (Supplementary Methods: Characterization 
for Organisms Recovered from Culture).Gram negative rods (GNR), Gram positive rods (GPR), 
Gram variable rods (BVR), Gram positive cocci (GPC), BBLTM Chocolate Agar (CHOC), 
BBLTM Sheep blood Agar (BAP), BBLTM MacConkey Agar (MAC), Chopped Meat Glucose 
Broth (CMG), BD BACTEC™ Peds Plus™ medium (PEDS), BD BACTEC™ Lytic Anaerobic 
medium (ANA). 
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Supplementary Table 10: Biochemical testing of P. thiaminolyticus. 
 
Tube 
# 
Test Carbohydrate Case 
report(107) 
Strain 
B-
4156 
Clinical 
Sample 2033 
Strain Mbale 
0 Control (NG = no growth) NG NG NG 
1 GLY glycerol + + + 
2 ERY erythritol - - - 
3 DARA D-arabinose - - - 
4 LARA L-arabinose - - - 
5 RIB D-ribose + + + 
6 DXYL D-xylose - - - 
7 LXYL L-xylose - - - 
8 ADO D-adonitol - - - 
9 MDX methyl-βD-
xylopyranoside 
- - - 
10 GAL D-galactose + (+) (+) 
11 GLU D-glucose + + + 
12 FRU D-fructose + + + 
13 MNE D-mannose + + + 
14 SBE L-sorbose - - - 
15 RHA L-rhamnose - - - 
16 DUL dulcitol - - - 
17 INO inositol - - - 
18 MAN D-mannitol - - - 
19 SOR D-sorbitol - - - 
20 MDM methyl-(alpha)D-
mannopyranoside 
- - - 
21 MDG methyl αD- 
glucopyranoside 
- (+) (+) 
22 NAG N-
acetylglucosamine 
+ + + 
23 AMY amygdalin + + + 
24 ARB arbutin + + + 
25 ESC esculin + + + 
26 SAL salicin + + + 
27 CEL D-cellobiose - (+) (+) 
28 MAL D-maltose + + + 
29 LAC D-lactose (bovine 
origin) 
- (+) (+) 
30 MEL D-melibiose + + + 
31 SAC D-saccharose + + + 
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32 TRE D-trehalose + + + 
33 INU inulin - - - 
34 MLZ D-melezitose - (+) (+) 
35 RAF D-raffinose + + + 
36 AMD amidon + + + 
37 GLYG glycogen + + - 
38 XLT xylitol - - - 
39 GEN gentiobiose + + + 
40 TUR D-turanose + + + 
41 LYX D-lyxose - - - 
42 TAG D-tagatose - - - 
43 DFUC D-fucose - - - 
44 LFUC L-fucose - - - 
45 DARL D-arabitol - - - 
46 LARL L-arabitol - - - 
47 GNT potassium 
gluconate 
+ (+) (+) 
48 2KG potassium 2-
ketogluconate 
- - - 
49 5KG potassium 5-
ketogluconate 
- - - 
Likelihood of P. thiaminolyticus 57.5% 99.9% 99.8% 
 
NG: No growth  
- Negative  
+ Positive  
(+) low / late positive  
 
24 Hours    48 Hours    
               B-4156 2033                     B-4156 2033  
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Supplementary Table 10. Biochemical testing of P. thiaminolyticus. API 50 CHB 
biochemical results for P. thiaminolyticus BKBLC 2156 as previously reported in the case report 
of Ouyang et al (2010)(107), contrasted with our testing of reference type strain NRRL B-4156, 
and our clinical isolate from patient sample 2033 strain type Mbale. The reference strain NRRL 
B-4156, and our clinical isolate type strain Mbale, were both identified as P. thiaminolyticus with 
99.8-99.9% confidence (https://apiweb.biomerieux.com). The clinical strain was tested 3 times, 
and while there was some variability at 24 h, it consistently identified as P. thiaminolyticus with 
high confidence at 48 h. 
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Supplementary Table 11: Antibiotic Resistance. 
 
Antibiotic 
P. thiaminolyticus Paenibacillus spp. 
MIC (µg/ml) Interpretation* MIC(µg/ml) Interpretation* 
Vancomycin 4 S 0.125 S 
Ciprofloxacin 0.064 S 0.25 S 
Penicillin 0.125 S 1.0 R 
Clindamycin 0. 5 S 2.0 I 
Ceftriaxone** 0.5 
 
0.5 
 
Gentamycin 2.0 S 0.032 S 
Tetracycline 0.25 S 0.064 S 
 
 
*S: Susceptible, R: Resistant, I: Intermediate 
** No interpretation by CLSI guidelines 
 
Supplementary Table 11. Antibiotic Resistance testing of the available antibiotics in the 
Ugandan population was performed on two clinical isolates of Paenibacillus that grew 
aerobically, using standard E-test sensitivity and interpretations given for ones that were 
interpretable with Clinical and Laboratory Standards Institute (CLSI) guidelines. The P. 
Thiaminolyticus Mbale isolate, which appeared to represent most of our samples, showed no 
antibiotic resistance while the Paenibacillus spp. was identified as resistant to penicillin with 
intermediate resistance to clindamycin. 
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Supplementary Table 12: Virulence Testing. 
 
* One mouse infected with the Mbale strain demonstrated signs of illness, but spontaneously 
recovered after 2 days. 
 
 
Supplementary Table 12. Summary of virulence testing. Of the 50 mice inoculated, only those 
receiving the Mbale strain displayed signs of sepsis and were moribund. The infection was only 
clinically evident at the highest undiluted dose (16/16). Diluted doses were not able to induce 
signs of infection (0/10). 
 
 
  
Inoculation Status 
[no. and % in each category] 
All mice 
n=50 
Moribund or Died 
n=16 
Normal 
n=34 
Mbale strain 26 (52) 16 (62) 10 (38) 
     Undiluted (~109 CFU/mL) 16/26 15/16 ⃰  0/16 
     Dilutions (below 109 CFU/mL) 10/26 0/10 10/10 
Reference strain 14 (28) 0 (0) 14 (100) 
Normal saline 10 (20) 0 (0)  10 (100) 
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